SlideShare a Scribd company logo
EPILEPSY AND SEIZURES- A DEEP
INSIGHT
PRESENTED BY:
VISHNU.R.NAIR,
4TH YEAR PHARM.D,
NATIONAL COLLEGE OF PHARMACY,
KERALA UNIVERSITY OF HEALTH SCIENCES(KUHS),
INDEX/CONTENTSOFTHISPPT:
1. GENERAL ACKNOWLEDGEMENT
2. GENERALIZED TERMINOLOGIES
3. EPIDEMIOLOGY
4. TYPES OF EPILEPSIES{INCLUDING CLINICAL
MANIFESTATIONS}
5. ETIOLOGY OF EPILEPSY
6. PATHOPHYSIOLOGY OF EPILEPSY
7. RISK FACTORS FOR SEIZURES
8. DIAGNOSIS OF EPILEPSY
9. MANAGEMENT STRATEGIES FOR EPILEPSY
 GENERAL ACKNOWLEDGEMENT  :
TO THE ALMIGHTY , MY NEAR AND DEAR ONES… AND TO
ALL READERS WORLDWIDE!!!
THANKFUL TO ALL FOR UR SUPPORT, GUIDANCE AND
ENCOURAGEMENT………………
ITS BEEN A REALLY HARD JOB WORKING ON THIS
PPT…………………
HOPE U LIKE IT!!
HAPPY READING!!!
  
 GENERALIZED TERMINOLOGIES  :
1. SEIZURE:
“PHENOMENON, characterized by an EXCESSIVE, HYPERSYNCHRONOUS
DISCHARGE of CORTICAL NEURONAL ACTIVITY, (measured by EEG), featured by
DISTURBANCES in CONSCIOUSNESS, SENSORY MOTOR SYSTEMS, SUBJECTIVE
WELL-BEING and OBJECTIVE BEHAVIOUR…………………”
2. EPILEPSY:
“CHRONIC SEIZURE DISORDER/ GROUP OF DISORDERS, characterized by SEIZURES,
that usually occur UNPREDICTABLY, in the ABSENCE of a SUBSTANTIAL PROVOKING
FACTOR…………….”
3. CONVULSION:
“VIOLENT, INVOLUNTARY CONTRACTIONS of VOLUNTARY MUSCLES, which may/
may not be present in epilepsy/ seizure disorder………..............”
 EPIDEMIOLOGY OF EPILEPSY  :
- Higher risk observed in extremes of age
- Prevalence in European countries is 0.5%
- Prevalence in developing countries is higher, due to parasitic illnesses like
CYSTICERCOSIS
- Around 50 million people worldwide have epilepsy
- Epilepsy responds to treatment in 70% cases
- 75% people in developing countries do not get required anti-epileptic
treatment…………………..
 TYPES OF EPILEPSIES (INCLUDING
CLINICAL MANIFESTATIONS)  :
Based on INTERNATIONAL LEAGUE AGAINST EPILEPSY(ILAE)
classification:
1. PARTIAL SEIZURES (FOCAL SEIZURES)
2. GENERALIZED SEIZURES ………………………………………
1. PARTIAL SEIZURES (FOCAL SEIZURES):
- Most common seizure type
- Localized to a neuronal system, limited to PART OF 1 CEREBRAL HEMISPHERE
- Types include:
A. SIMPLE PARTIAL SEIZURES:
- Not associated with loss of consciousness
- Associated with:
i. MOTOR SIGNS (Convulsive jerking, lip smacking)
ii. SENSORY & SOMATOSENSORY SIGNS (Paresthesias, auras)
iii. AUTONOMIC SIGNS (Sweating, flushing)
iv. BEHAVIOURAL MANIFESTATIONS (Dysphasia, structured hallucinations)
B. COMPLEX PARTIAL SEIZURES:
- Associated with IMPAIRED CONSCIOUSNESS
- Impairment precedes/ follows seizures
- Associated with:
i. Purposeless behavior
ii. Glassy stare
iii. Aimless walking
iv. Hallucinations (visual, auditory)
v. Aggressive behaviour……………………………….
2. GENERALIZED SEIZURES:
- Diffuse seizures
- Affect BOTH CEREBRAL HEMISPHERES
- Types include:
A. IDIOPATHIC EPILEPSIES:
- Age related onset
- Also congenital (genetic origin)
B. SYMPTOMATIC EPILEPSIES:
- Aftermath of a DOCUMENTED UNDERLYING CNS DISORDER
C. CRYPTOGENIC EPILEPSY:
- Cause unknown
- Presumed to be age- related
Manifestations of generalized seizures include:
A. ABSENCE SEIZURES:
- Also known as ‘PETIT MAL’ seizures
- Alterations of consciousness, lasting 10-30 mins. Occurs
- Associated with:
a. Staring, with occasional eye-blinking
b. Enuresis
B. MYOCLONIC SEIZURES:
- Also known as ‘BILATERAL MASSIVE EPILEPTIC MYOCLONUS’
- Associated with INCVOLUNTARY, RHYTHMIC JERKING of FACIAL, LIMB/ TRUNK
MUSCLES
C. CLONIC SEIZURES:
- Associated with SUSTAINED MUSCLE CONTRACTIONS, alternating with
RELAXATION
D. TONIC SEIZURES:
- Associated with SUSTAINED MUSCLE CONTRACTIONS (Stiffening)
E. GENERALIZED TONIC-CLONIC SEIZURES (GTCS):
- Also known as ‘GRAND MAL’ seizures
- Causes sudden loss of consciousness
- Individual becomes rigid and falls to the ground
- Interrupted respirations
- Extended legs
- Lasts for 1 min.
- Rapid bilateral muscle jerking
- Heavy salivation, tongue biting, headache, confusion
- In some cases, GRAND MAL seizures occurs repeatedly, with no recovery of consciousness
between attacks, leading to state known as ‘STATUS EPILEPTICUS’………………..
F. ATONIC SEIZURES:
- Also known as ‘DROP ATTACKS’
- Sudden loss of postural tone  individual falls to the ground
- Occurs mainly in children…………………………………..
 ETIOLOGY OF EPILEPSY  :
Mainly we will see the causes of:
A. FOCAL SEIZURES
B. GENERALIZED SEIZURES…………………………..
1. CAUSES OF FOCAL SEIZURES:
Include:
A. IDIOPATHIC REASONS:
- Benign ROLANDIC epilepsy of childhood (Discovered by Italian Anatomist Luigi Rolando)
- Benign OCCIPITAL epilepsy of childhood
B. GENETIC REASONS:
- Tuberous sclerosis (characterized by tiny benign tumours {angiofibromas} on the face, skin, and
abnormalities of kidney, brain and heart)
- Autosomal dominant frontal lobe epilepsy
- Autosomal dominant partial epilepsy with auditory features (ADPEAF)
- Von Hippel-Lindau disease (characterized by hemangioblastomas {benign blood vessel tumours } in
brain, spinal cord, retina; kidney cysts & cancer and pheochoromocytomas}
- Neurofibromatosis (causes tumours to grow on nerves and inhibits neural growth)
- Cerebral migration abnormalities
C. INFANTILE HEMIPLEGIA (acute hemiparesis, that occurs in infancy, caused
by vascular accidents, like cerebral infarction or thrombosis)
D. DYSEMBRYONIC CAUSES:
- Cortical dysgenesis
- Sturge-Weber syndrome (mainly affects the skin, featured by ‘port wine stain birthmark’;
also known as ‘Encephalotrigeminal angiomatosis’)
E. MESIAL TEMPORAL SEIZURES:
- Associated with febrile convulsions
F. CEREBROVASCULAR DISEASES:
- Intracerebral hemorrhage
- Cerebral infarction
- Arteriovenous malformation
- Cavernous hemangioma (occurs on body surface, as red or purplish, blood filled lakes/
channels)
G. PRIMARY AND SECONDARY TUMOURS
H. TRAUMA (including neurosurgery)
I. INFECTIVE CAUSES:
- Cerebral abscess (pyogenic) - Toxoplasmosis - Cysticercosis - Tuberculoma
- Subdural empyema - Encephalitis - HIV infections
J. INFLAMMATORY CAUSES:
- Sarcoidosis - Vasculitis………………………..
2. CAUSES OF GENERALIZED SEIZURES :
Includes:
A. GENETICS:
- Inborn metabolism errors - Storage diseases - Phacomatoses (Tuberous
sclerosis)
B. CEREBRAL BIRTH INJURY
C. HYDROCEPHALUS
D. CEREBRAL ANOXIA
E. ALCOHOL WITHDRAWAL
F. TOXINS:
- Organophosphates (SARIN)
- Heavy metals (LEAD, TIN)
G. DRUGS:
- ANTIBIOTICS (Penicillin, metronidazole, Isoniazid)
- ANTIMALARIALS (Chloroquine, mefloquine)
- CYCLOSPORINE
- ANTI-ARRRHYTHMICS (Lidocaine, disopyramide)
- PSYCHOTROPICS (Phenothiazines, TCAs, Lithium)
- AMPHETAMINE WITHDRAWAL
H. METABOLIC DISEASE :
- Hypocalcemia
- Hyponatremia
- Hypomagnesemia
- Hypoglycemia
- Renal failure
- Liver failure
I. INFECTIVE CAUSES:
- Post- infective encephalopathy
- Meningitis
J. INFLAMMATORY CAUSES:
- Multiple sclerosis
- SLE
K. DIFFUSE DEGENERATIVE DISEASES:
- Alzheimer’s disease
- CREUTZFELDT- JAKOB DISEASE (Degenerative, invariably fatal brain disorder,
associated with failing memory ,behaviour changes, weakness of extremities, mental
deterioration and coma)……………………………..
 PATHOPHYSIOLOGY OF EPILEPSY 
:1. Neurons are inter-connected in a complex network
2. Each individual neuron  linked via synapses with hundreds of others
3. Neurons  discharge electrical current  neurotransmitters are released at synaptic levels
 permits inter- communication
4. Neurotransmitters are of 2 types:
a. INHIBITORY NEUROTRANSMITTER (GABA):
- GABA (Gamma amino butyric acid )  acts on ion channels  increases chloride inflow
 decreases chances of action potential formation
b. EXCITATORY NEUROTRANSMITTER ( ASPARTATE, GLUTAMATE):
- Above agents  allow sodium and calcium influx  paves way for action potential
formation
5. In this manner, information is conveyed, transmitted and processed throughout the CNS
6. Imbalance between above excitation and inhibition  seizures occur
7. A normal neuron discharges repetitively at LOW BASELINE FREQUENCIES
8. If neurons are damaged, injured/ suffer a chemical/ metabolic insult  changes in discharge
pattern develops
9. During epilepsy  regular low frequency discharges are replaced by BURSTS of HIGH
FREQUENCY DISCHARGES  followed by periods of INACTIVITY
10. A single neuron discharging in an abnormal manner is usually not clinically significant
11. When a WHOLE POPULATION of NEURONS DISCHARGE SYNCHRONOUSLY in an
ABNORMAL MANNER  EPILEPTIC SEIZURE IS PRECIPITATED
12. This abnormal discharge may remain LOCALIZED/ it may SPREAD TO ADJACENT
AREAS, RECRUITING MORE NEURONS as it EXPANDS…………………………….
 RISK FACTORS FOR EPILEPSIES  :
1. Sleep deprivation
2. Missed doses of anti-epileptic drugs(AEDs) in treated patients
3. Alcohol withdrawals
4. Recreational drug misuse
5. Physical and mental exhaustion
6. Flickering lights (includes TV, computer screens; comes under generalized epilepsy
syndrome)
7. Intercurrent infections
8. Metabolic disturbances
9. UNCOMMON REASONS:
- Loud noises
- Very hot baths…………………………………
 DIAGNOSIS OF EPILEPSIES  :
Based on the following criteriae:
1. TO CHECK THE LOCATION OF EPILEPTIC
ORIGIN:
- Standard EEG
- Sleep EEG
- EEG, with special electrodes
2. TO CHECK FOR STRUCTURAL LESIONS:
- CT SCAN - MRI SCAN
3. FOR METABOLIC DISORDER DIAGNOSIS:
- Urea and electrolytes - LFTs
- Blood glucose levels - Serum calcium and magnesium levels
4. FOR INFLAMMATORY/ INFECTIVE DISORDER
DIAGNOSIS:
- CBC - ESR - CRP TEST - CHEST XRAY
- SEROLOGY FOR SYPHILIS, HIV, COLLAGEN DISEASE
- CSF EXAMINATION
5. FOR CONFIRMING ATTACKS TO BE OF EPILEPTIC
ORIGIN:
- Ambulatory EEG - Video telemetry
6. BRAIN IMAGING:
Indicated for:
- Epilepsy starting after 16 yrs. of age
- Seizures, with clinical focal features
- EEG, showing a focal seizure source
 MANAGEMENT OF EPILEPSY  :
 Includes:
1. GOALS OF THERAPY
2. GENERAL GUIDELINES FOR ANTICONVULSANT
THERAPY
3. PHARMACOTHERAPY
4. GUIDELINES FOR CHOICE OF ANTI-EPILEPTIC
DRUGS(AEDs)
5. NON-PHARMACOTHERAPY/ PATIENT- COUNSELLING
TIPS+ HOME REMEDIES FOR EPILEPSY
 1. GOALS OF THERAPY  :
1. To control and reduce SEIZURE FREQUENCY
2. To focus on MINIMUM POSSIBLE DOSAGE OF AEDs
3. To minimize ADRs associated with therapy
4. To ensure PATIENT MEDICATION COMPLIANCE
5. To ensure that person lives a normal life as far as possible
6. To balance COMPLETE SUPPRESSION of SEIZURES against ADR TOLERABILITY
7. To reduce MORBIDITY and MORTALITY
8. To improve QUALITY OF LIFE(QOL)………………………………..
 2. GENERAL GUIDELINES FOR
ANTICONVULSANT THERAPY : 
1. Start with 1 FIRST LINE DRUG
2. Start with a low dose  gradually increase dose until effective control of seizures is
achieved/ ADRs develop
3. Optimize compliance (use minimum no. of doses/ day)
4. If 1st line drug fails (seizures continue/ ADRs develop)  start 2nd (1st line drug) , followed
(if possible) , by gradual withdrawal of the drug presently being used
5. If 2nd line drug fails (due to above reasons)  start 2nd line drug, in combination with
preferred 1st line drug at maximum tolerated doses (keep in mind possible interactions)
6. If above combination fails (due to above reasons)  replace 2nd line drug with alternative
2nd line drug
7. If above combination fails (due to above reasons)  check compliance & reconsider
diagnosis, based on the following criteriae:
a. If the events are seizures/ not
b. Presence absence of occult lesions
c. Treatment compliance/ alcohol/ drugs confounding responses
8. Consider alternative, non-drug treatments, like:
a. Epilepsy surgery
b. Vagal nerve stimulation
9. Use minimum number of drugs in combination at any one time………………………….
 3. PHARMACOTHERAPY : 
A. BARBITURATES :
Include:
I. PHENOBARBITONE (LUMINAL):
- Drug has 3 actions:
a. Drug  depresses sensory, motor cortex and cerebellum
b. Drug  acts on GABA(A) receptors  increases synaptic inhibition  increases seizure
threshold and decreases spread of seizure activity from a seizure focus
c. Drug  inhibits CALCIUM channels  decreases excitatory transmitter release
- ADR :
a. Sedation c. Headache
b. Respiratory depression (when given i.v)
- DRUG INTERACTION:
a. Phenobarbital + oral contraceptives  decreased efficacy of latter
- USES:
a. Febrile convulsions (8 mg/kg/day; child)
b. GTC c. Neonatal seizures d. Status Epilepticus (SE)
B. DEOXYBARBITURATES :
Includes:
I. PRIMIDONE (MYSOLINE):
- MOA:
Drug  enters body  metabolized by liver to PHENOBARBITONE  Shows remaining effects
- ADR:
a. STEVEN-JOHNSON SYNDROME (SJS)
b. Hypotension
c. Hepatitis
- DRUG INTERACTION:
a. BZDs + Drug  increased sedation
- USES:
A. GTCS (250-500 mg BD)
B. Partial epilepsy
C. HYDANTOINS :
Includes:
A. PHENYTOIN (BARBITOIN):
- Drug has 3 actions:
i. Drug  promotes sodium efflux/ decreased sodium influx from membranes in motor
cortex neurons
ii. Drug  stabilizes neuronal membranes
iii. Drug  slows conduction velocity
- ADR:
i. Gingival hyperplasia
ii. Hirsutism
iii. Megaloblastic anemia
iv. Diabetes mellitus
v. FETAL HYDANTOIN SYNDROME (Drug  used in pregnancy  causes hare lips,
microcephaly in neonates etc)
- DRUG INTERACTIONS:
a. Drug + Pyridoxine(in high dose)  decreased levels of phenytoin
- USES:
a. Tonic clonic seizures
b. SE (10-15 mg/kg i.v/ infusion)
B. FOSPHENYTOIN (FOSPHEN):
- MOA:
Drug  converted to PHENYTOIN after injection  shows actions of PHENYTOIN
- ADR:
a. Hypersensitivity b. SJS c. Hepatotoxicity
- DRUG INTERACTIONS:
a. Drug + CBZ(Carbamazepine)  decreased CBZ efficacy
- USES:
a. Seizures, associated with NEUROSURGERY/ HEAD INJURY
b. SE (20 mg/kg i.v)………….
D. IMINOSTILBENES :
Includes:
A. CARBAMAZEPINE (CARBATOL):
- Drug shows 2 actions:
i. Drug  stabilizes inactivated state of sodium channels  makes neurons less excitable
ii. Drug  decreases activity of NUCLEUS VENTRALIS of thalamus / synaptic
transmission associated with neuronal discharge
- ADR:
a. SJS b. Arrhythmia c. CHF
- DRUG INTERACTIONS:
a. Drug + warfarin  decreased anticoagulant effect
- USES :
a. Trigeminal neuralgia c. Epilepsy (200-400 mg TDS)
b. Bipolar disorder
B. OXCARBAZEPINE (CARBOX):
- Drug shows 5 actions:
i. Drug  blocks sodium channels  stabilizes neuronal membranes
ii. Drug  inhibits repetitive firing
iii. Drug  reduces synaptic impulse propagation
iv. Drug  increases potassium conductance
v. Drug  modulates activity of high voltage activated calcium channels
- ADR:
a. SJS b. Hepatitis c. Pancreatitis
- DRUG INTERACTION:
a. Furosemide + drug  increased risk of HYPONATREMIA
- USES :
a. Partial seizures , with/ without secondary generalization (in adults: 0.6-2.4 g/day, in divided
doses)……………………
E. SUCCINIMIDES:
Includes:
A. ETHOSUXIMIDE (ZARONTIN):
- Drug shows 2 actions:
i. Drug  depresses nerve transmission in motor cortex
ii. Drug  increases convulsive stimuli threshold in CNS
- ADR:
a. GI disturbances b. Dizziness
- DRUG INTERACTION:
a. Drug + sodium oxybate  pharmacodynamic synergism  increased toxicity of each
other  additive CNS depression
- USE:
a. Absence seizures : 500 mg P/O QID…………………….
F. ALIPHATIC CARBOXYLIC ACIDS:
Includes:
I. VALPROIC ACID (VALPROL):
- Drug shows 3 actions:
i. Drug  increases GABA levels in brain
ii. Drug  increases / mimics action of GABA at postsynaptic receptor sites
iii. Drug  inhibits sodium and calcium channels
- ADR:
a. SJS b. Pancreatitis c. Thrombocytopenia
- DRUG INTERACTION:
a. Drug + Chlorpromazine  severe HEPATOTOXICITY
- USES:
a. Complex partial seizures (For adults: max. 60 mg/kg/day)
b. Simple and complex absence seizures…………………..
II. DIVALPROEX (DIVAA):
- MOA : Same as that of SODIUM VALPROATE
- ADR:
a. Increased bleeding time
b. Encephalopathy
c. Dementia
- DRUG INTERACTION :
a. Drug + cholestyramine  decreased levels of divalproex
- USES :
a. Complex partial seizures (max.: 60 mg/kg/day)
b. Mania
c. Migraine prophylaxis
d. Simple and complex absence seizures………………………………
G. BENZODIAZEPINES :
Includes:
I. CLONAZEPAM (CLONA):
- Long acting BZD
- Drug shows 3 actions:
a. Drug  increases presynaptic GABA inhibition
b. Drug  decreases monosynaptic and polysynaptic reflexes
c. Drug  facilitates GABA neurotransmission and other inhibitory neurotransmitters 
suppresses muscle contractions
- ADR:
a. Blood disorders b. Increased LFTs c. Respiratory depression
- DRUG INTERACTION:
a. Amiodarone + drug  increased drug toxicity
- USES:
a. Panic disorder
b. Seizure disorders (For adult: up to 1.5 g , in 3 divided doses)
c. SE
II. CLOBAZAM (CLOBA):
- 1,5- BENZODIAZEPINE (Contrary to others)
- MOA:
Drug  binds to GABA(A) receptor  potentiates GABA- ergic neurotransmission
- ADR:
a. Hypotension b. Respiratory depression c. Jaundice
- DRUG INTERACTION:
a. CBZ + Clobazam  decreased drug levels
b. Alcohol + Clobazam  increased drug levels
III. DIAZEPAM (DIZEP):
- Drug shows 2 actions:
a. Drug  modulates postsynaptic effects of GABA(A) transmission  results in an
increase in presynaptic inhibition
b. Drug  acts on part of limbic system, thalamus and hypothalamus  induces CALMING
EFFECT
- ADR:
a. Respiratory depression
b. Hypotension
c. Jaundice
- DRUG INTERACTION:
a. Hormonal contraceptives + Drug  increased drug effects  increased incidence of
BREATH-THROUGH BLEEDING
- USES:
a. STATUS EPILEPTICUS (Adult: 5-10 mg every 5-10 mins. ; maximum 30 mg.)
b. Anxiety
c. Conscious sedation for procedures
d. Ethanol withdrawal
e. Insomnia associated with anxiety
f. Muscle spasm with tetanus
g. Night terrors
h. Sedation
i. Skeletal muscle relaxation
j. Sleep walking………………………………..
IV. LORAZEPAM (LOPEZ):
- Short onset of effect
- Long half-life
- Drug shows 2 actions:
a. Drug  increases action of GABA
b. Drug  depresses all levels of CNS, including lumbar and reticular formation
- ADR:
a. Respiratory depression b. Hypotension c. Jaundice
- DRUG INTERACTIONS:
a. Loxapine + drug  increased respiratory depression
b. Zidovudine + drug  increased headache
- USES:
a. Antiemetic (adjuvant therapy)
b. Acute anxiety
c. Insomnia associated with anxiety
d. Panic disorder
e. Pre-operative medication
f. Sedation
g. SE (For adult: 4 mg; repeat once after 10 mins, if necessary)………………………..
H. PHENYLTRIAZINES:
Includes:
LAMOTRIGINE (LAMORIN):
- Drug shows 2 actions:
a. Drug  inhibits release of excitatory amino acids (glutamate)
b. Drug  inhibits voltage sensitive sodium channels  stabilizes neuronal membranes
- ADR:
a. SJS b. DIC c. Lymphadenopathy
- DRUG INTERACTION:
a. Drug + Phenytoin/Phenobarbital  decreases levels of drug
- USES:
a. Bipolar disorder
b. GTC( For adult: 25 mg/day for initial 14 days  then increase dose to 50 mg/day for next
14 days  then increase dose to 50-100 mg/day for next 7-14 days)……………………..
I. CYCLIC GABA ANALOGUES:
Includes:
A. GABAPENTIN (GABAPENTIN):
- Structurally related to GABA, but has no effect on GABA binding, uptake/ degradation
- MOA:
Drug  modulates voltage sensitive calcium channels  decreases entry of calcium into
presynaptic neurons  decreases glutamate release  decreases neuronal excitability
- ADR :
a. SJS b. ARF c. Hepatitis
- DRUG INTERACTION:
a. Drug + phenytoin/antacids decreased levels of latter
- USES:
a. Diabetic neuropathy
b. Focal seizures, with/ without secondary generalization (For child: 12-18 yrs  300 mg
TID/ 0.9-3.6g/day ,in 3 divided doses)
c. Restless legs syndrome
d. Post- therpetic neuralgia / neuropathic pain………………
B. PREGABALIN (PREGALIN):
- Drug shows 2 actions:
i. Drug  binds to a subunit of voltage gated calcium channels in CNS  remaining same
as GABAPENTIN
ii. Does not affect sodium channels
- ADR:
a. Primary AV block b. CHF c. SJS
- DRUG INTERACTIONS:
a. Drug + Lorazepam/ alcohol  increased efficacy of latter
- USES:
a. Partial seizures, with/ without secondary generalization (50-300 mg/day, in 2-3 divided
doses, for adults; maximum: 600 mg/day)
b. Anxiety
c. Peripheral and central neuropathic pain
d. Fibromyalgia……………………………..
J. NEWER DRUGS:
Include:
I .TOPIRAMATE
II.ZONISAMIDE
III. LEVETIRACETAM
IV. VIGABATRIN
V. TIAGABINE
VI. LACOSAMIDE
VII. FELBAMATE
VIII. RUFINAMIDE
IX. STIRIPENTOL
X. ESLICARBAZEPINE ACETATE
XI. PERAMPANEL…………………………………..
I. TOPIRAMATE (TOPIRATE):
- CLASS: SULFAMATE SUBSTITUTED DERIVATIVE
- Drug shows 2 actions:
a. Drug  inhibits neuronal voltage dependent sodium channels
b. Drug  enhances activity of GABA
- ADR:
a. SJS b. Thrombocytopenia c. Toxic epidermal necrolysis(TEN)
- DRUG INTERACTION:
a. Zonisamide+ drug  increased risk of renal calculi
- USES:
a. Epilepsy (200-1000 mg/day)
b. Migraine prophylaxis
c. Partial seizures……………………………….
II. ZONISAMIDE (ZONICARE):
- CLASS: SULFONAMIDE DERIVATIVE (Benzisoxazole compound)
- Drug shows 3 actions:
a. Drug  acts at sodium and calcium channels  stabilizes neuronal membranes
b. Does not affect GABA activity
c. More active against TONIC PHASE than against CLONIC PHASE
- ADR:
a. SJS b. TEN c. Rhabdomyolysis
- DRUG INTERACTION:
a. CBZ+ Zonisamide  decreased level of Zonisamide (by affecting CYP3A4 metabolism)
- USES:
a. Partial seizures, with/ without secondary generalization (300-500 mg/ day; in 1-2 divided
doses)……………………………………..
III. LEVETIRACETAM (LEVACETAM):
- CLASS: PYRROLIDINE DERIVATIVE
- Drug shows 3 actions:
a. Drug  inhibits voltage dependent N-TYPE CALCIUM CHANNELS
b. Drug  binds to synaptic proteins  modulate neurotransmitter release
c. Drug  displaces negative modulators  facilitates GABA- ergic inhibitory transmission
- DRUG INTERACTION:
a. CBZ + Drug  CBZ toxicity occurs
- ADR:
a. Thrombocytopenia b. Pancreatitis c. Hepatic dysfunction
- USES:
a. GTC (Max: 1.5 g BID; For adults)
b. Myoclonic seizures
c. Partial seizures, with or without secondary generalization………………….
IV. VIGABATRIN (SABRIL):
- CLASS: GAMMA-VINYL GABA DERIVATIVE
- MOA:
Drug  irreversibly inhibits GABA-transaminase  increases GABA levels in brain
- ADR:
a. Weight gain in children (47%)
b. Permanent bilateral concentric visual field constriction (>30%)
c. Fatigue (28%)
- DRUG INTERACTION:
a. Drug + CLOBAZAM  Increased sedation, respiratory depression
- USES:
a. Complex seizures (1.5 g BID)
b. Partial seizures
c. Infantile spasms
d. Refractory complex seizures………………………….
V. TIAGABINE (GABITRIL):
- CLASS: GABA REUPTAKE INHIBITOR
- MOA:
drug  blocks GABA reuptake by presynaptic neuron  increases its activity in nervous
system
- ADR:
a. Dizziness (26-30%)
b. Asthenia (16-20%)
c. Somnolence (16-20%)
- DRUG INTERACTION:
a. Drug + Clobazam  increased sedation/ respiratory depression
- USES:
a. Partial seizures (with hepatic enzyme inducing anticonvulsants)
b. Partial seizures (without hepatic enzyme inducing anticonvulsants; 12-22 mg/day , divided
in 2-3 doses)…………………………………
VI. LACOSAMIDE (LACOSAM):
- CLASS : HOMOSERINAMIDE DERIVATIVE; FUNTIONAL AMINO ACID
- Drug shows 2 actions:
a. Drug  slowly inactivates voltage gated sodium channels
b. Drug  binds to collapsin response mediator protein-2 (CRMP-2); a phosphoprotein;
expressed mainly in nervous system  modulates neuronal differentiation and axonal
outgrowth
- ADR:
a. Dizziness (31%) d. Atrial fibrillation
b. Diplopia (11%) e. Atrial flutter
c. Headache (11%) f. Suicidal ideation
- DRUG INTERACTION:
a. Drug + anti- arrhythmics  enhanced PR-prolongation
- USES:
a. Neuropathic pain b. Partial seizures (200-400 mg/day)…….
VII. FELBAMATE (FELBATOL):
- CLASS : CARBAMATE DERIVATIVE
- Drug shows 2 actions:
a. Drug  positive modulator of GABA(A) receptor
b. Drug  blocks NMDA receptors (NR2B subunit)
- ADR:
a. Anorexia
b. Liver failure
c. Aplastic anemia
- DRUG INTERACTION:
a. Felbamate + clopidogrel  decreased effects of clopidogrel
- USES:
a. Partial seizures, with/ without secondary generalization (Adults: 1,200 mg Q6H/Q8H)
b. Partial/ Generalized seizures , associated with LENNOX-GASTAUT SYNDROME …….
VIII. RUFINAMIDE (BANZEL):
- CLASS : TRIAZOLE DERIVATIVE
- MOA:
Drug  modulates activity of sodium channels  prolongs their inactive state  limits
repetitive firing of sodium dependent action potentials  anticonvulsant effect
- ADR:
a. Diplopia
b. SJS
c. Dizziness
- DRUG INTERACTION :
a. Rufinamide + alprazolam  decreased levels/ effects of latter
- USE:
a. LENNOX-GASTAUT SYNDROME (3,200 mg/day maximum, in 2 divided
doses)……………………………..
IX. STIRIPENTOL (DIACOMIT):
- CLASS: AROMATIC ALLYLIC ALCOHOLS
- Drug shows 5 actions:
a. Drug  increases GABA transmission
b. Drug  increases duration of opening of GABA(A) receptor channels in hippocampal
areas  enhances central GABA transmission
c. Drug  increases GABA levels in brain tissues by interfering with its uptake &
metabolism
d. Drug  inhibits LACTATE DEHYDROGENASE  Makes neurons less prone to fire
action potentials
e. Drug  improves effectiveness of other anti-convulsants……………
- ADR:
a. Hyperkinesia
b. Drowsiness
c. Ataxia
- DRUG INTERACTION:
a. Drug + CBZ/ Phenobarbital  increased efficacy/ potency of latter
- USES:
a. DRAVET SYNDROME (Along with sodium valproate and Clobazam; 50 mg/kg/day)
b. Epilepsy in infancy
c. Refractory childhood epilepsy( in combination with CBZ)………….
X. ESLICARBAZEPINE ACETATE (ESLIZEN):
- CLASS : DIBENZAPINE CARBOXAMIDE DERIVATIVE
- Drug shows 3 actions:
a. PRODRUG  activated to ESLICARBAZEPINE/ S-LICARBAZEPINE (Major active
metabolite of OXCARBAZEPINE)  Blocks sodium channels  inhibits repetitive firing
 decreases synaptic impulse propagation  stabilizes neuronal membranes
b. Drug  increases potassium conductance
c. Drug  modulates activity of high voltage gated activated calcium channels
- ADR:
a. Blurred vision
b. HTN
c. Peripheral edema
- DRUG INTERACTION:
a. Drug + Phenytoin/ Barbiturates  decreased drug levels
- USE:
a. Partial onset seizures (for adult: 400 mg/day; for 7 days)……………….
XI. PERAMPANEL (FYCOMPA):
- CLASS : NON-COMPETITIVE AMPA RECEPTOR ANTAGONIST)
- MOA:
Drug  non- competitively blocks ALPHA-AMINO-3-HYDROXY-5-METHYL-4-
ISOXAZOLEPROPIONIC ACID (AMPA ) glutamate receptor on post synaptic neurons 
decreased glutamate activity  decreases neurological disorders causes by glutamate over-
excitation
- ADR:
a. Dizziness (16-43%)
b. Somnolence (9-18%)
c. Suicidal ideation (notorious)
- DRUG INTERACTION:
a. Drug +CBZ  Decreased perampanel effectiveness
- USES:
a. Partial onset seizures (8-12 mg/day) b. Tonic clonic seizures……………….
 4. GUIDELINES FOR CHOICE OF
ANTI-EPILEPTIC DRUGS  :
A. FOR FOCAL ONSET AND / SECONDARY GTCS:
- IST LINE DRUG : LAMOTRIGINE
- 2ND LINE DRUGS : CBZ, LEVETIRACETAM, VALPROIC ACID, TOPIRAMATE ,
ZONISAMIDE, LACOSAMIDE
- 3RD LINE DRUGS: CLOBAZAM, GABAPENTIN, OXCARBAZEPINE,
BARBITURATES , PHENYTOIN, PREGABALIN, PRIMIDONE, TIAGABINE…..
B. FOR GTCS:
- 1ST LINE DRUGS : VALPROIC ACID, LEVETIRACETAM
- 2ND LINE DRUGS : LAMOTRIGINE, TOPIRAMATE, ZONISAMIDE
- 3RD LINE DRUGS : CBZ, PHENYTOIN, PRIMIDONE, BARBITURATES……………
C. FOR ABSENCE SEIZURES :
- 1ST LINE DRUG : ETHOSUXIMIDE
- 2ND LINE DRUGS : SODIUM VALPROATE
- 3RD LINE DRUGS : LAMOTRIGINE, CLONAZEPAM……………
D. FOR MYOCLONIC SEIZURES:
- 1ST LINE DRUG: SODIUM VALPROATE
- 2ND LINE DRUGS : LEVETIRACETAM, CLONAZEPAM
- 3RD LINE DRUGS : LAMOTRIGINE, PHENOBARBITAL………………………
 5. NON-
PHARMACOTHERAPY/PATIENT-
COUNSELLING TIPS +HOME
REMEDIES FOR EPILEPSY  :1. AVOID ACTIVITIES, WHERE PATIENTS MAY PLACE
THEMSELVES/ OTHERS AT RISK, IF THEY HAVE A
SEIZURE (APPLIES AT WORK, HOME/ AT LEISURE)
2. TAKE ONLY SHALLOW BATHS/ SHOWERS
3. AVOID PROLONGED CYCLE JOURNEYS ,UNLESS
REASONABLE FREEDOM FROM SEIZURES HAS BEEN
ACHIEVED
4. ACTIVITIES, THAT REQUIRE PROLONGED PROXIMITY TO
WATER (FISHING SWIMMINING,BOATING ) SHOULD BE
5. RECONGIZED MORTALITY OF EPILEPSY SHOULD BE
DISCUSSED AT THE TIME OF DIAGNOSIS, AIMED AT
MOTIVATING THE PATIENT, TO ADAPT TO HABITS AND
LIFESTYLE, TO OPTIMIZE EPILEPSY CONTROL
6. COCONUT OIL:
- Highly effective
- Fatty acids (medium chain triglycerides) in oil  possess therapeutic effects on brain cells
- Oil  supplies energy for brain cells  relieves epilepsy symptoms
- Use 1-3 tsp of EXTRA VIRGIN COCONUT OIL (3 times a day)
7. EPSOM SALT:
- EPSOM SALT  Contains magnesium sulphate  changes psychochemical cell
relationships in the brain  reduces frequency of seizures and convulsions
- Use in the form of:
a. Epsom salt bath (2-3 times/ week)
b. Add half tsp of salt to orange juice / water  drink every morning
8. LIME:
- Popular Ayurvedic remedy
- Lime  helps improve blood circulation to brain
- Also normalizes excess calcium that may hamper brain functionality
- Use in the form of:
a. (2 tsp. lime juice + half tsp. baking soda + water)  drink daily before going to bed
b. Apply lime juice on head  massage thoroughly for a few mins.  do daily before taking a
shower
9. GARLIC:
- Garlic  possesses ANTIOXIDANT, ANTISPASMODIC & ANTI-INFLAMMATORY
PROPERTIES  Promotes proper functioning of nervous, along with destruction of harmful free
radicals in body  prevents seizures and related symptoms
- Use it in the form of:
a. Mix half cup of milk + half cup water  boil  add 4-5 crushed garlic cloves  strain and drink it
once daily
b. Garlic supplements (under doctor advice)
10. PASSIONFLOWER :
- Herb  contains CHRYSIN  increases GABA amount in brain  decreases seizures frequency,
anxiety
- Use it in the form of :
a. CAPSULE, TABLET FORMS
b. HERBAL TEA (1-2 CUPS)
- Avoid in pregnancy/ lactation
11. WINTER MELON:
- Also known as ‘ASH GOURD’
- Popular Ayurvedic remedy
- Vegetable  helps keeps nervous system healthy
- Also ensures smooth functioning of brain cells
- Use in the form of:
a. Half glass winter melon juice + little sugar  drink in the morning on empty stomach
b. Extract juice of crushed winter melon  add 1-2 tsp licorice powder to it  mix well  drink this
solution once daily
12. EXERCISE :
- Improves fitness, energy and mood  reduces seizures and impact of epilepsy on one’s life
- Exercise  releases positive feeling hormones into brain  increases oxygen flow to brain
- Go for warm up/ stretching exercises
- Walk for 45 mins. , 4 times a week
- Drink water before and after exercise to prevent dehydration
- Stop and rest if you are feeling tired
13. YOGA:
- Alleviates stress
- Induces relaxation
- Combination of DEEP BREATHING, PHYSICAL POSTURES AND MEDITATION 
Controls seizures and reduces other epilepsy symptoms
- Best yoga poses for epilepsy are:
a. Balasana(child’s pose) b. Nadi shodhana(alternate nostril breathing)
c. Kapotasana (pigeon pose) d. Sirsasana (headstand)
14. VITAMINS:
- Certain vitamins  control neurons that cause seizures and anxiety disorders
- Consume the following Vitamin supplements after doctor consultation:
a. Vitamin E b. Vitamin B6 c. Vitamin B1 d. Vitamin D e. Vitamin B12
15. ACCUPUNCTURE:
- “Phenomenon of applying pressure to specific points on the body, by using fine needles”
- Acupuncture  restores flow of energy throughout the body  alters brain activity  reduces
seizures
16. COUNSELLING TIPS IN PREGNANCY:
- Start FOLIC ACID 5 mg daily for 2 months before conception , to reduce risk of AED induced fetal
abnormalities
- Since some AEDs are associated with hemorrhage risk, give oral Vitamin K 20 mg daily to mother
during last month of pregnancy, and Vitamin K (1 mg i.m ) to infant at birth
17. GET ENOUGH SLEEP, AS SLEEP DEPRIVATION
TRIGGERS SEIZURES
18. MANAGE STRESS AND AVOID STRESSFUL SITUATIONS
19. IF YOU HAVE SEIZURES REGULARLY, WEAR A
‘MEDICAL ALERT BRACELET’  THIS WILLHELP PEOPLE
TO KNOW ABOUT YOUR CONDITION
20. DRINK HALF GLASS OF GRAPE JUICE DAILY
21. LIMIT ALCOHOL INTAKE
22. AVOID SMOKING
23. LOW CALCIUM AND MAGNESIUM  TRIGGERS
SEIZURES  CONSUME FOODS RICH IN THEM
24. AVOID ALL ‘WHITE PRODUCTS’ LIKE:
a. White sugar
b. White flour
c. Table salt
d. White rice
25. DO NOT SKIP MEALS, ESPECIALLY BREAKFAST
26. DO NOT CONSUME ARTIFICIAL SWEETENERS/
ADDITIVES
27. TAKE MEDICINES PRESCRIBED BY DOCTOR IN
CORRECT DOSAGES IN A TIMELY MANNER
28. DO NOT SKIP TAKING YOUR MEDICINES WITHOUT
DOCTOR’S APPROVAL
29. AVOID USAGE OF GINGKO BILOBA AND ST.JOHN’S
WORT FOR EPILEPSY ,UNLESS UNDER DOCTOR’S ADVICE
(SINCE THEY CAN INTERACT WITH AEDs)
30. FOLLOW A KETOGENIC DIET, COMPRISING:
a. High fat(nuts, cream, butter)
b. Low carbohydrate (starchy fruits, bread, pasta, grains,
sugar)
 BIBLIOGRAPHY/ REFERENCE  :
1. DAVENPORT.J.R; LEACH.P.J; ‘NEUROLOGICAL DISEASE:EPILEPSY’;DAVIDSON’S
PRINCIPLES AND PRACTICE OF MEDICINE; 22ND EDITION; Pg:1178-85
2. Tripathi.K.D; “Essentials of medical pharmacology”; 7th edition; Jaypee Publishers; “Anti-
epileptic drugs’; Pg:411-424
3. Dhillon.S; Sander.W.J; “Clinical pharmacy and therapeutics”; by Roger Walker; 5th edition;
“Epilepsy”; Pg: 489
4. Wells.G.Barbera;”Epilepsy”; Pharmacotherapy Handbook; by Joseph.T.Dipiro; Pg: 577
5. www.healthline.com
6. www.drugbank.com
7. www.webmd.com
8. http://www.thelancet.com/journals/abstract/’Top 10 home remedies To deal with Epilepsy’
9. Razzhaghi.A; “Seizure disorders”; “Comprehensive Pharmacy Review for NAPLEX by LEON
SHARGEL”; 8TH EDITION; Pg:743
10. Mc.Namara.C.J; “Pharmacotherapy of the Epilepsies”; Goodman & Gilman’s Pharmacological
basis of Therapeutics; 11th edition; Pg: 501
THANK YOU!!!   
@rxvichu-alwz4uh!!

More Related Content

What's hot

Drug induced hematological disorders @rxvichu!!!
Drug induced hematological disorders @rxvichu!!!Drug induced hematological disorders @rxvichu!!!
Drug induced hematological disorders @rxvichu!!!
RxVichuZ
 
Cerebrovascular disease
Cerebrovascular diseaseCerebrovascular disease
Cerebrovascular disease
avatar73
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Soujanya Pharm.D
 
Bayesian theory
Bayesian theoryBayesian theory
Bayesian theory
pavithra vinayak
 
Antidotes and its clinical application
Antidotes and its clinical applicationAntidotes and its clinical application
Antidotes and its clinical application
kritijain857168
 
SOFTWARE USED IN P'epidemiology.pdf
SOFTWARE USED IN P'epidemiology.pdfSOFTWARE USED IN P'epidemiology.pdf
SOFTWARE USED IN P'epidemiology.pdf
varshawadnere
 
Systematic approach to answer Poison Information Query
Systematic approach to answer Poison Information QuerySystematic approach to answer Poison Information Query
Systematic approach to answer Poison Information Query
Dr. Abhimanyu Prashar
 
Pharmacotherapy of Schizophrenia
Pharmacotherapy of SchizophreniaPharmacotherapy of Schizophrenia
Pharmacotherapy of Schizophrenia
Koppala RVS Chaitanya
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.DDr.Sohel Memon
 
Applications of computers in Hospital Pharmacy- By RxVichuZ!
Applications of computers in Hospital Pharmacy- By RxVichuZ!Applications of computers in Hospital Pharmacy- By RxVichuZ!
Applications of computers in Hospital Pharmacy- By RxVichuZ!
RxVichuZ
 
Pharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacistPharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacist
Dr. Ramesh Bhandari
 
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
RxVichuZ
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
Dr. Irfan Ahmad Khan
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
Dr. Ramesh Bhandari
 
Elimination enhancement
Elimination enhancementElimination enhancement
Elimination enhancement
velspharmd
 
Pathophysiology of Schizophrenia
Pathophysiology of Schizophrenia Pathophysiology of Schizophrenia
Pathophysiology of Schizophrenia Urmila Aswar
 
Pharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's DiseasePharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's Disease
Harshad Malve
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
Dr. Siddhartha Dutta
 
7. g) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).pptx
7. g) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).pptx7. g) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).pptx
7. g) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).pptx
Anusha Are
 

What's hot (20)

Drug induced hematological disorders @rxvichu!!!
Drug induced hematological disorders @rxvichu!!!Drug induced hematological disorders @rxvichu!!!
Drug induced hematological disorders @rxvichu!!!
 
Cerebrovascular disease
Cerebrovascular diseaseCerebrovascular disease
Cerebrovascular disease
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
 
Bayesian theory
Bayesian theoryBayesian theory
Bayesian theory
 
Antidotes and its clinical application
Antidotes and its clinical applicationAntidotes and its clinical application
Antidotes and its clinical application
 
SOFTWARE USED IN P'epidemiology.pdf
SOFTWARE USED IN P'epidemiology.pdfSOFTWARE USED IN P'epidemiology.pdf
SOFTWARE USED IN P'epidemiology.pdf
 
Systematic approach to answer Poison Information Query
Systematic approach to answer Poison Information QuerySystematic approach to answer Poison Information Query
Systematic approach to answer Poison Information Query
 
Pharmacotherapy of Schizophrenia
Pharmacotherapy of SchizophreniaPharmacotherapy of Schizophrenia
Pharmacotherapy of Schizophrenia
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.D
 
Applications of computers in Hospital Pharmacy- By RxVichuZ!
Applications of computers in Hospital Pharmacy- By RxVichuZ!Applications of computers in Hospital Pharmacy- By RxVichuZ!
Applications of computers in Hospital Pharmacy- By RxVichuZ!
 
Pharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacistPharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacist
 
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
Home remedies and patient counselling tips for ANEMIA-By rxvichu-alwz4uh!! :) :)
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
 
Elimination enhancement
Elimination enhancementElimination enhancement
Elimination enhancement
 
Pathophysiology of Schizophrenia
Pathophysiology of Schizophrenia Pathophysiology of Schizophrenia
Pathophysiology of Schizophrenia
 
Pharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's DiseasePharmacotherapy of Alzheimer's Disease
Pharmacotherapy of Alzheimer's Disease
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
7. g) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).pptx
7. g) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).pptx7. g) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).pptx
7. g) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).pptx
 

Viewers also liked

Epilepsy.....
Epilepsy.....Epilepsy.....
Epilepsy.....
Ravneet Singh
 
Newer drugs approved by US-FDA - Rxvichu!!!
Newer drugs approved by US-FDA - Rxvichu!!!Newer drugs approved by US-FDA - Rxvichu!!!
Newer drugs approved by US-FDA - Rxvichu!!!
RxVichuZ
 
Refractory epilepsy in children
Refractory epilepsy in children Refractory epilepsy in children
Refractory epilepsy in children
Khaled Saad
 
Renal function tests - a deep insight by rxvichu!
Renal function tests - a deep insight by rxvichu!Renal function tests - a deep insight by rxvichu!
Renal function tests - a deep insight by rxvichu!
RxVichuZ
 
Restless leg syndrome
Restless leg syndromeRestless leg syndrome
Restless leg syndrome
aprameyarajput3
 
Peptic ulcer disease a brief insight- by rxvichu!!!!
Peptic ulcer disease  a brief insight- by rxvichu!!!!Peptic ulcer disease  a brief insight- by rxvichu!!!!
Peptic ulcer disease a brief insight- by rxvichu!!!!
RxVichuZ
 
Local anaesthetics – a brief outlook by Rxvichu!!
Local anaesthetics – a brief outlook by Rxvichu!!Local anaesthetics – a brief outlook by Rxvichu!!
Local anaesthetics – a brief outlook by Rxvichu!!
RxVichuZ
 
Seizure Disorders
Seizure Disorders Seizure Disorders
Seizure Disorders
Maha Alkhalifah
 
Fibroid uterus a deep insight - by rxvichu ;)
Fibroid uterus  a deep insight - by rxvichu ;)Fibroid uterus  a deep insight - by rxvichu ;)
Fibroid uterus a deep insight - by rxvichu ;)
RxVichuZ
 
Recent Advances in migraine
Recent Advances in migraine Recent Advances in migraine
Recent Advances in migraine
DR ANUP PETARE
 
Seizures disorder
Seizures disorderSeizures disorder
Seizures disorder
Saim Jam
 
Epilepsy- classification and types in children. Download to see videos.
Epilepsy- classification and types in children. Download to see videos.Epilepsy- classification and types in children. Download to see videos.
Epilepsy- classification and types in children. Download to see videos.
Tarun Prudvi Betha
 
Hospital – its functions, types and organization- By rxvichu !!! :)
Hospital – its functions, types and organization- By rxvichu !!! :)Hospital – its functions, types and organization- By rxvichu !!! :)
Hospital – its functions, types and organization- By rxvichu !!! :)
RxVichuZ
 
Eshaan Potential Appraisal
Eshaan Potential AppraisalEshaan Potential Appraisal
Eshaan Potential AppraisalEshaan Chhagotra
 
Antiepileptics (New) - drdhriti
Antiepileptics (New) - drdhritiAntiepileptics (New) - drdhriti
Antiepileptics (New) - drdhriti
http://neigrihms.gov.in/
 
AP1 Presentation - Epilepsy
AP1 Presentation - EpilepsyAP1 Presentation - Epilepsy
AP1 Presentation - EpilepsyMacia Noorman
 
Epilepsy case study presentation
Epilepsy case study presentationEpilepsy case study presentation
Epilepsy case study presentation
Amy00Good
 
Pathophysiology of migraine
Pathophysiology of migrainePathophysiology of migraine
Pathophysiology of migrainewebzforu
 

Viewers also liked (20)

Epilepsy.....
Epilepsy.....Epilepsy.....
Epilepsy.....
 
Newer drugs approved by US-FDA - Rxvichu!!!
Newer drugs approved by US-FDA - Rxvichu!!!Newer drugs approved by US-FDA - Rxvichu!!!
Newer drugs approved by US-FDA - Rxvichu!!!
 
Refractory epilepsy in children
Refractory epilepsy in children Refractory epilepsy in children
Refractory epilepsy in children
 
Renal function tests - a deep insight by rxvichu!
Renal function tests - a deep insight by rxvichu!Renal function tests - a deep insight by rxvichu!
Renal function tests - a deep insight by rxvichu!
 
Restless leg syndrome
Restless leg syndromeRestless leg syndrome
Restless leg syndrome
 
Peptic ulcer disease a brief insight- by rxvichu!!!!
Peptic ulcer disease  a brief insight- by rxvichu!!!!Peptic ulcer disease  a brief insight- by rxvichu!!!!
Peptic ulcer disease a brief insight- by rxvichu!!!!
 
Local anaesthetics – a brief outlook by Rxvichu!!
Local anaesthetics – a brief outlook by Rxvichu!!Local anaesthetics – a brief outlook by Rxvichu!!
Local anaesthetics – a brief outlook by Rxvichu!!
 
Seizure Disorders
Seizure Disorders Seizure Disorders
Seizure Disorders
 
Fibroid uterus a deep insight - by rxvichu ;)
Fibroid uterus  a deep insight - by rxvichu ;)Fibroid uterus  a deep insight - by rxvichu ;)
Fibroid uterus a deep insight - by rxvichu ;)
 
Recent Advances in migraine
Recent Advances in migraine Recent Advances in migraine
Recent Advances in migraine
 
Epilepsia
EpilepsiaEpilepsia
Epilepsia
 
Seizures disorder
Seizures disorderSeizures disorder
Seizures disorder
 
Epilepsy- classification and types in children. Download to see videos.
Epilepsy- classification and types in children. Download to see videos.Epilepsy- classification and types in children. Download to see videos.
Epilepsy- classification and types in children. Download to see videos.
 
Hospital – its functions, types and organization- By rxvichu !!! :)
Hospital – its functions, types and organization- By rxvichu !!! :)Hospital – its functions, types and organization- By rxvichu !!! :)
Hospital – its functions, types and organization- By rxvichu !!! :)
 
Eshaan Potential Appraisal
Eshaan Potential AppraisalEshaan Potential Appraisal
Eshaan Potential Appraisal
 
Antiepileptics (New) - drdhriti
Antiepileptics (New) - drdhritiAntiepileptics (New) - drdhriti
Antiepileptics (New) - drdhriti
 
AP1 Presentation - Epilepsy
AP1 Presentation - EpilepsyAP1 Presentation - Epilepsy
AP1 Presentation - Epilepsy
 
Epilepsy case study presentation
Epilepsy case study presentationEpilepsy case study presentation
Epilepsy case study presentation
 
SEIZURE
SEIZURESEIZURE
SEIZURE
 
Pathophysiology of migraine
Pathophysiology of migrainePathophysiology of migraine
Pathophysiology of migraine
 

Similar to Epilepsy and seizures a deep insight- by Rxvichu!!

1 # CNS symptoms history taking.pdf
1 #  CNS symptoms history taking.pdf1 #  CNS symptoms history taking.pdf
1 # CNS symptoms history taking.pdf
UgiYou
 
Dementia
DementiaDementia
Dementia
drsherifsaad
 
4-IMMUNOLOGY.pdf
4-IMMUNOLOGY.pdf4-IMMUNOLOGY.pdf
4-IMMUNOLOGY.pdf
LawrenceNamalata1
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
Mohamed Rizk Khodair
 
Organic Brain Syndrome.pptx
Organic Brain Syndrome.pptxOrganic Brain Syndrome.pptx
Organic Brain Syndrome.pptx
VandanaGaur8
 
Alzheimers disease.e.pptx
Alzheimers disease.e.pptxAlzheimers disease.e.pptx
Alzheimers disease.e.pptx
BishalKunwor2
 
Epilleptic disorder for nursing, medicine , biomedical and psychiatry student...
Epilleptic disorder for nursing, medicine , biomedical and psychiatry student...Epilleptic disorder for nursing, medicine , biomedical and psychiatry student...
Epilleptic disorder for nursing, medicine , biomedical and psychiatry student...
yetalb
 
Autonomic nervous system dysautonomia.pptx
Autonomic nervous system dysautonomia.pptxAutonomic nervous system dysautonomia.pptx
Autonomic nervous system dysautonomia.pptx
mohamed elshafei
 
Brain Tumors.ppt
Brain Tumors.pptBrain Tumors.ppt
Brain Tumors.ppt
VarunKishore14
 
What is Epilepsy?
What is Epilepsy?What is Epilepsy?
Organic mental disorder
Organic mental disorderOrganic mental disorder
Organic mental disorder
Priyanka Kumari
 
Neurodegenerative Dementia..pptx
Neurodegenerative  Dementia..pptxNeurodegenerative  Dementia..pptx
Neurodegenerative Dementia..pptx
Thuyamani M
 
Cerebrovascular Disorders
Cerebrovascular DisordersCerebrovascular Disorders
Cerebrovascular Disorders
Jack Frost
 
Cerebrovascular Disorders
Cerebrovascular DisordersCerebrovascular Disorders
Cerebrovascular Disorders
Jack Frost
 
Dementia
DementiaDementia
Dementia
KISHORSUPET
 
Approach to peripheral neuropathy
Approach to peripheral neuropathyApproach to peripheral neuropathy
Approach to peripheral neuropathy
Mohamed Ahmed Tarek
 
Medicina felina convulsions
Medicina felina   convulsionsMedicina felina   convulsions
Medicina felina convulsions
Guillaume Michigan
 
ALD.pptx
ALD.pptxALD.pptx
ALD.pptx
Thuyamani M
 
Organic brain syndrome
Organic brain syndromeOrganic brain syndrome
Organic brain syndromeHala Sayyah
 
Cns Neuropathy Davidson07.
Cns Neuropathy  Davidson07.Cns Neuropathy  Davidson07.
Cns Neuropathy Davidson07.
Shaikhani.
 

Similar to Epilepsy and seizures a deep insight- by Rxvichu!! (20)

1 # CNS symptoms history taking.pdf
1 #  CNS symptoms history taking.pdf1 #  CNS symptoms history taking.pdf
1 # CNS symptoms history taking.pdf
 
Dementia
DementiaDementia
Dementia
 
4-IMMUNOLOGY.pdf
4-IMMUNOLOGY.pdf4-IMMUNOLOGY.pdf
4-IMMUNOLOGY.pdf
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Organic Brain Syndrome.pptx
Organic Brain Syndrome.pptxOrganic Brain Syndrome.pptx
Organic Brain Syndrome.pptx
 
Alzheimers disease.e.pptx
Alzheimers disease.e.pptxAlzheimers disease.e.pptx
Alzheimers disease.e.pptx
 
Epilleptic disorder for nursing, medicine , biomedical and psychiatry student...
Epilleptic disorder for nursing, medicine , biomedical and psychiatry student...Epilleptic disorder for nursing, medicine , biomedical and psychiatry student...
Epilleptic disorder for nursing, medicine , biomedical and psychiatry student...
 
Autonomic nervous system dysautonomia.pptx
Autonomic nervous system dysautonomia.pptxAutonomic nervous system dysautonomia.pptx
Autonomic nervous system dysautonomia.pptx
 
Brain Tumors.ppt
Brain Tumors.pptBrain Tumors.ppt
Brain Tumors.ppt
 
What is Epilepsy?
What is Epilepsy?What is Epilepsy?
What is Epilepsy?
 
Organic mental disorder
Organic mental disorderOrganic mental disorder
Organic mental disorder
 
Neurodegenerative Dementia..pptx
Neurodegenerative  Dementia..pptxNeurodegenerative  Dementia..pptx
Neurodegenerative Dementia..pptx
 
Cerebrovascular Disorders
Cerebrovascular DisordersCerebrovascular Disorders
Cerebrovascular Disorders
 
Cerebrovascular Disorders
Cerebrovascular DisordersCerebrovascular Disorders
Cerebrovascular Disorders
 
Dementia
DementiaDementia
Dementia
 
Approach to peripheral neuropathy
Approach to peripheral neuropathyApproach to peripheral neuropathy
Approach to peripheral neuropathy
 
Medicina felina convulsions
Medicina felina   convulsionsMedicina felina   convulsions
Medicina felina convulsions
 
ALD.pptx
ALD.pptxALD.pptx
ALD.pptx
 
Organic brain syndrome
Organic brain syndromeOrganic brain syndrome
Organic brain syndrome
 
Cns Neuropathy Davidson07.
Cns Neuropathy  Davidson07.Cns Neuropathy  Davidson07.
Cns Neuropathy Davidson07.
 

More from RxVichuZ

Parkinson Disease Pathophysiology #Dr. Vishnu!
Parkinson Disease Pathophysiology #Dr. Vishnu!Parkinson Disease Pathophysiology #Dr. Vishnu!
Parkinson Disease Pathophysiology #Dr. Vishnu!
RxVichuZ
 
HIV Pathophysiology, by Dr. Vishnu
HIV Pathophysiology, by Dr. VishnuHIV Pathophysiology, by Dr. Vishnu
HIV Pathophysiology, by Dr. Vishnu
RxVichuZ
 
General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)
RxVichuZ
 
Buprenorphine drug profile by Dr. Vishnu!
Buprenorphine drug profile by Dr. Vishnu!Buprenorphine drug profile by Dr. Vishnu!
Buprenorphine drug profile by Dr. Vishnu!
RxVichuZ
 
5-Alpha reductase inhibitors drug profile
5-Alpha reductase inhibitors drug profile5-Alpha reductase inhibitors drug profile
5-Alpha reductase inhibitors drug profile
RxVichuZ
 
Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!
RxVichuZ
 
Co-trimoxazole drug profile by RxVichuZ!
Co-trimoxazole drug profile by RxVichuZ!Co-trimoxazole drug profile by RxVichuZ!
Co-trimoxazole drug profile by RxVichuZ!
RxVichuZ
 
Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)
RxVichuZ
 
Food drug interactions with penicillins: by RxVichuZ!
Food drug interactions with penicillins: by RxVichuZ!Food drug interactions with penicillins: by RxVichuZ!
Food drug interactions with penicillins: by RxVichuZ!
RxVichuZ
 
Snake bite poisoning and its treatment by RxVichuZ!
Snake bite poisoning and its treatment by RxVichuZ!Snake bite poisoning and its treatment by RxVichuZ!
Snake bite poisoning and its treatment by RxVichuZ!
RxVichuZ
 
Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!
RxVichuZ
 
Directly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case reportDirectly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case report
RxVichuZ
 
Drug mnemonics; by RxVichuZ! ;)
Drug mnemonics; by RxVichuZ! ;)Drug mnemonics; by RxVichuZ! ;)
Drug mnemonics; by RxVichuZ! ;)
RxVichuZ
 
Acute coronary syndrome management by RxVichuZ! ;)
Acute coronary syndrome management by RxVichuZ! ;)Acute coronary syndrome management by RxVichuZ! ;)
Acute coronary syndrome management by RxVichuZ! ;)
RxVichuZ
 
RNTCP guidelines for tuberculosis management: Extended version
RNTCP guidelines for tuberculosis management: Extended versionRNTCP guidelines for tuberculosis management: Extended version
RNTCP guidelines for tuberculosis management: Extended version
RxVichuZ
 
Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)
RxVichuZ
 
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
RxVichuZ
 
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insightDipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
RxVichuZ
 
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
RxVichuZ
 
Sulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insightSulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insight
RxVichuZ
 

More from RxVichuZ (20)

Parkinson Disease Pathophysiology #Dr. Vishnu!
Parkinson Disease Pathophysiology #Dr. Vishnu!Parkinson Disease Pathophysiology #Dr. Vishnu!
Parkinson Disease Pathophysiology #Dr. Vishnu!
 
HIV Pathophysiology, by Dr. Vishnu
HIV Pathophysiology, by Dr. VishnuHIV Pathophysiology, by Dr. Vishnu
HIV Pathophysiology, by Dr. Vishnu
 
General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)
 
Buprenorphine drug profile by Dr. Vishnu!
Buprenorphine drug profile by Dr. Vishnu!Buprenorphine drug profile by Dr. Vishnu!
Buprenorphine drug profile by Dr. Vishnu!
 
5-Alpha reductase inhibitors drug profile
5-Alpha reductase inhibitors drug profile5-Alpha reductase inhibitors drug profile
5-Alpha reductase inhibitors drug profile
 
Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!
 
Co-trimoxazole drug profile by RxVichuZ!
Co-trimoxazole drug profile by RxVichuZ!Co-trimoxazole drug profile by RxVichuZ!
Co-trimoxazole drug profile by RxVichuZ!
 
Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)
 
Food drug interactions with penicillins: by RxVichuZ!
Food drug interactions with penicillins: by RxVichuZ!Food drug interactions with penicillins: by RxVichuZ!
Food drug interactions with penicillins: by RxVichuZ!
 
Snake bite poisoning and its treatment by RxVichuZ!
Snake bite poisoning and its treatment by RxVichuZ!Snake bite poisoning and its treatment by RxVichuZ!
Snake bite poisoning and its treatment by RxVichuZ!
 
Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!
 
Directly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case reportDirectly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case report
 
Drug mnemonics; by RxVichuZ! ;)
Drug mnemonics; by RxVichuZ! ;)Drug mnemonics; by RxVichuZ! ;)
Drug mnemonics; by RxVichuZ! ;)
 
Acute coronary syndrome management by RxVichuZ! ;)
Acute coronary syndrome management by RxVichuZ! ;)Acute coronary syndrome management by RxVichuZ! ;)
Acute coronary syndrome management by RxVichuZ! ;)
 
RNTCP guidelines for tuberculosis management: Extended version
RNTCP guidelines for tuberculosis management: Extended versionRNTCP guidelines for tuberculosis management: Extended version
RNTCP guidelines for tuberculosis management: Extended version
 
Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)
 
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
 
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insightDipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
 
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
 
Sulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insightSulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insight
 

Recently uploaded

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 

Recently uploaded (20)

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 

Epilepsy and seizures a deep insight- by Rxvichu!!

  • 1. EPILEPSY AND SEIZURES- A DEEP INSIGHT PRESENTED BY: VISHNU.R.NAIR, 4TH YEAR PHARM.D, NATIONAL COLLEGE OF PHARMACY, KERALA UNIVERSITY OF HEALTH SCIENCES(KUHS),
  • 2. INDEX/CONTENTSOFTHISPPT: 1. GENERAL ACKNOWLEDGEMENT 2. GENERALIZED TERMINOLOGIES 3. EPIDEMIOLOGY 4. TYPES OF EPILEPSIES{INCLUDING CLINICAL MANIFESTATIONS} 5. ETIOLOGY OF EPILEPSY 6. PATHOPHYSIOLOGY OF EPILEPSY 7. RISK FACTORS FOR SEIZURES 8. DIAGNOSIS OF EPILEPSY 9. MANAGEMENT STRATEGIES FOR EPILEPSY
  • 3.  GENERAL ACKNOWLEDGEMENT  : TO THE ALMIGHTY , MY NEAR AND DEAR ONES… AND TO ALL READERS WORLDWIDE!!! THANKFUL TO ALL FOR UR SUPPORT, GUIDANCE AND ENCOURAGEMENT……………… ITS BEEN A REALLY HARD JOB WORKING ON THIS PPT………………… HOPE U LIKE IT!! HAPPY READING!!!   
  • 4.  GENERALIZED TERMINOLOGIES  : 1. SEIZURE: “PHENOMENON, characterized by an EXCESSIVE, HYPERSYNCHRONOUS DISCHARGE of CORTICAL NEURONAL ACTIVITY, (measured by EEG), featured by DISTURBANCES in CONSCIOUSNESS, SENSORY MOTOR SYSTEMS, SUBJECTIVE WELL-BEING and OBJECTIVE BEHAVIOUR…………………” 2. EPILEPSY: “CHRONIC SEIZURE DISORDER/ GROUP OF DISORDERS, characterized by SEIZURES, that usually occur UNPREDICTABLY, in the ABSENCE of a SUBSTANTIAL PROVOKING FACTOR…………….” 3. CONVULSION: “VIOLENT, INVOLUNTARY CONTRACTIONS of VOLUNTARY MUSCLES, which may/ may not be present in epilepsy/ seizure disorder………..............”
  • 5.  EPIDEMIOLOGY OF EPILEPSY  : - Higher risk observed in extremes of age - Prevalence in European countries is 0.5% - Prevalence in developing countries is higher, due to parasitic illnesses like CYSTICERCOSIS - Around 50 million people worldwide have epilepsy - Epilepsy responds to treatment in 70% cases - 75% people in developing countries do not get required anti-epileptic treatment…………………..
  • 6.  TYPES OF EPILEPSIES (INCLUDING CLINICAL MANIFESTATIONS)  : Based on INTERNATIONAL LEAGUE AGAINST EPILEPSY(ILAE) classification: 1. PARTIAL SEIZURES (FOCAL SEIZURES) 2. GENERALIZED SEIZURES ………………………………………
  • 7. 1. PARTIAL SEIZURES (FOCAL SEIZURES): - Most common seizure type - Localized to a neuronal system, limited to PART OF 1 CEREBRAL HEMISPHERE - Types include: A. SIMPLE PARTIAL SEIZURES: - Not associated with loss of consciousness - Associated with: i. MOTOR SIGNS (Convulsive jerking, lip smacking) ii. SENSORY & SOMATOSENSORY SIGNS (Paresthesias, auras) iii. AUTONOMIC SIGNS (Sweating, flushing) iv. BEHAVIOURAL MANIFESTATIONS (Dysphasia, structured hallucinations)
  • 8. B. COMPLEX PARTIAL SEIZURES: - Associated with IMPAIRED CONSCIOUSNESS - Impairment precedes/ follows seizures - Associated with: i. Purposeless behavior ii. Glassy stare iii. Aimless walking iv. Hallucinations (visual, auditory) v. Aggressive behaviour……………………………….
  • 9. 2. GENERALIZED SEIZURES: - Diffuse seizures - Affect BOTH CEREBRAL HEMISPHERES - Types include: A. IDIOPATHIC EPILEPSIES: - Age related onset - Also congenital (genetic origin) B. SYMPTOMATIC EPILEPSIES: - Aftermath of a DOCUMENTED UNDERLYING CNS DISORDER C. CRYPTOGENIC EPILEPSY: - Cause unknown - Presumed to be age- related
  • 10. Manifestations of generalized seizures include: A. ABSENCE SEIZURES: - Also known as ‘PETIT MAL’ seizures - Alterations of consciousness, lasting 10-30 mins. Occurs - Associated with: a. Staring, with occasional eye-blinking b. Enuresis B. MYOCLONIC SEIZURES: - Also known as ‘BILATERAL MASSIVE EPILEPTIC MYOCLONUS’ - Associated with INCVOLUNTARY, RHYTHMIC JERKING of FACIAL, LIMB/ TRUNK MUSCLES C. CLONIC SEIZURES: - Associated with SUSTAINED MUSCLE CONTRACTIONS, alternating with RELAXATION
  • 11. D. TONIC SEIZURES: - Associated with SUSTAINED MUSCLE CONTRACTIONS (Stiffening) E. GENERALIZED TONIC-CLONIC SEIZURES (GTCS): - Also known as ‘GRAND MAL’ seizures - Causes sudden loss of consciousness - Individual becomes rigid and falls to the ground - Interrupted respirations - Extended legs - Lasts for 1 min. - Rapid bilateral muscle jerking - Heavy salivation, tongue biting, headache, confusion - In some cases, GRAND MAL seizures occurs repeatedly, with no recovery of consciousness between attacks, leading to state known as ‘STATUS EPILEPTICUS’………………..
  • 12. F. ATONIC SEIZURES: - Also known as ‘DROP ATTACKS’ - Sudden loss of postural tone  individual falls to the ground - Occurs mainly in children…………………………………..
  • 13.  ETIOLOGY OF EPILEPSY  : Mainly we will see the causes of: A. FOCAL SEIZURES B. GENERALIZED SEIZURES…………………………..
  • 14. 1. CAUSES OF FOCAL SEIZURES: Include: A. IDIOPATHIC REASONS: - Benign ROLANDIC epilepsy of childhood (Discovered by Italian Anatomist Luigi Rolando) - Benign OCCIPITAL epilepsy of childhood B. GENETIC REASONS: - Tuberous sclerosis (characterized by tiny benign tumours {angiofibromas} on the face, skin, and abnormalities of kidney, brain and heart) - Autosomal dominant frontal lobe epilepsy - Autosomal dominant partial epilepsy with auditory features (ADPEAF) - Von Hippel-Lindau disease (characterized by hemangioblastomas {benign blood vessel tumours } in brain, spinal cord, retina; kidney cysts & cancer and pheochoromocytomas} - Neurofibromatosis (causes tumours to grow on nerves and inhibits neural growth) - Cerebral migration abnormalities
  • 15. C. INFANTILE HEMIPLEGIA (acute hemiparesis, that occurs in infancy, caused by vascular accidents, like cerebral infarction or thrombosis) D. DYSEMBRYONIC CAUSES: - Cortical dysgenesis - Sturge-Weber syndrome (mainly affects the skin, featured by ‘port wine stain birthmark’; also known as ‘Encephalotrigeminal angiomatosis’) E. MESIAL TEMPORAL SEIZURES: - Associated with febrile convulsions F. CEREBROVASCULAR DISEASES: - Intracerebral hemorrhage - Cerebral infarction - Arteriovenous malformation - Cavernous hemangioma (occurs on body surface, as red or purplish, blood filled lakes/ channels)
  • 16. G. PRIMARY AND SECONDARY TUMOURS H. TRAUMA (including neurosurgery) I. INFECTIVE CAUSES: - Cerebral abscess (pyogenic) - Toxoplasmosis - Cysticercosis - Tuberculoma - Subdural empyema - Encephalitis - HIV infections J. INFLAMMATORY CAUSES: - Sarcoidosis - Vasculitis………………………..
  • 17. 2. CAUSES OF GENERALIZED SEIZURES : Includes: A. GENETICS: - Inborn metabolism errors - Storage diseases - Phacomatoses (Tuberous sclerosis) B. CEREBRAL BIRTH INJURY C. HYDROCEPHALUS D. CEREBRAL ANOXIA E. ALCOHOL WITHDRAWAL F. TOXINS: - Organophosphates (SARIN) - Heavy metals (LEAD, TIN)
  • 18. G. DRUGS: - ANTIBIOTICS (Penicillin, metronidazole, Isoniazid) - ANTIMALARIALS (Chloroquine, mefloquine) - CYCLOSPORINE - ANTI-ARRRHYTHMICS (Lidocaine, disopyramide) - PSYCHOTROPICS (Phenothiazines, TCAs, Lithium) - AMPHETAMINE WITHDRAWAL H. METABOLIC DISEASE : - Hypocalcemia - Hyponatremia - Hypomagnesemia - Hypoglycemia - Renal failure - Liver failure
  • 19. I. INFECTIVE CAUSES: - Post- infective encephalopathy - Meningitis J. INFLAMMATORY CAUSES: - Multiple sclerosis - SLE K. DIFFUSE DEGENERATIVE DISEASES: - Alzheimer’s disease - CREUTZFELDT- JAKOB DISEASE (Degenerative, invariably fatal brain disorder, associated with failing memory ,behaviour changes, weakness of extremities, mental deterioration and coma)……………………………..
  • 20.  PATHOPHYSIOLOGY OF EPILEPSY  :1. Neurons are inter-connected in a complex network 2. Each individual neuron  linked via synapses with hundreds of others 3. Neurons  discharge electrical current  neurotransmitters are released at synaptic levels  permits inter- communication 4. Neurotransmitters are of 2 types: a. INHIBITORY NEUROTRANSMITTER (GABA): - GABA (Gamma amino butyric acid )  acts on ion channels  increases chloride inflow  decreases chances of action potential formation b. EXCITATORY NEUROTRANSMITTER ( ASPARTATE, GLUTAMATE): - Above agents  allow sodium and calcium influx  paves way for action potential formation 5. In this manner, information is conveyed, transmitted and processed throughout the CNS 6. Imbalance between above excitation and inhibition  seizures occur
  • 21. 7. A normal neuron discharges repetitively at LOW BASELINE FREQUENCIES 8. If neurons are damaged, injured/ suffer a chemical/ metabolic insult  changes in discharge pattern develops 9. During epilepsy  regular low frequency discharges are replaced by BURSTS of HIGH FREQUENCY DISCHARGES  followed by periods of INACTIVITY 10. A single neuron discharging in an abnormal manner is usually not clinically significant 11. When a WHOLE POPULATION of NEURONS DISCHARGE SYNCHRONOUSLY in an ABNORMAL MANNER  EPILEPTIC SEIZURE IS PRECIPITATED 12. This abnormal discharge may remain LOCALIZED/ it may SPREAD TO ADJACENT AREAS, RECRUITING MORE NEURONS as it EXPANDS…………………………….
  • 22.  RISK FACTORS FOR EPILEPSIES  : 1. Sleep deprivation 2. Missed doses of anti-epileptic drugs(AEDs) in treated patients 3. Alcohol withdrawals 4. Recreational drug misuse 5. Physical and mental exhaustion 6. Flickering lights (includes TV, computer screens; comes under generalized epilepsy syndrome) 7. Intercurrent infections 8. Metabolic disturbances 9. UNCOMMON REASONS: - Loud noises - Very hot baths…………………………………
  • 23.  DIAGNOSIS OF EPILEPSIES  : Based on the following criteriae: 1. TO CHECK THE LOCATION OF EPILEPTIC ORIGIN: - Standard EEG - Sleep EEG - EEG, with special electrodes 2. TO CHECK FOR STRUCTURAL LESIONS: - CT SCAN - MRI SCAN 3. FOR METABOLIC DISORDER DIAGNOSIS: - Urea and electrolytes - LFTs - Blood glucose levels - Serum calcium and magnesium levels
  • 24. 4. FOR INFLAMMATORY/ INFECTIVE DISORDER DIAGNOSIS: - CBC - ESR - CRP TEST - CHEST XRAY - SEROLOGY FOR SYPHILIS, HIV, COLLAGEN DISEASE - CSF EXAMINATION 5. FOR CONFIRMING ATTACKS TO BE OF EPILEPTIC ORIGIN: - Ambulatory EEG - Video telemetry 6. BRAIN IMAGING: Indicated for: - Epilepsy starting after 16 yrs. of age - Seizures, with clinical focal features - EEG, showing a focal seizure source
  • 25.  MANAGEMENT OF EPILEPSY  :  Includes: 1. GOALS OF THERAPY 2. GENERAL GUIDELINES FOR ANTICONVULSANT THERAPY 3. PHARMACOTHERAPY 4. GUIDELINES FOR CHOICE OF ANTI-EPILEPTIC DRUGS(AEDs) 5. NON-PHARMACOTHERAPY/ PATIENT- COUNSELLING TIPS+ HOME REMEDIES FOR EPILEPSY
  • 26.  1. GOALS OF THERAPY  : 1. To control and reduce SEIZURE FREQUENCY 2. To focus on MINIMUM POSSIBLE DOSAGE OF AEDs 3. To minimize ADRs associated with therapy 4. To ensure PATIENT MEDICATION COMPLIANCE 5. To ensure that person lives a normal life as far as possible 6. To balance COMPLETE SUPPRESSION of SEIZURES against ADR TOLERABILITY 7. To reduce MORBIDITY and MORTALITY 8. To improve QUALITY OF LIFE(QOL)………………………………..
  • 27.  2. GENERAL GUIDELINES FOR ANTICONVULSANT THERAPY :  1. Start with 1 FIRST LINE DRUG 2. Start with a low dose  gradually increase dose until effective control of seizures is achieved/ ADRs develop 3. Optimize compliance (use minimum no. of doses/ day) 4. If 1st line drug fails (seizures continue/ ADRs develop)  start 2nd (1st line drug) , followed (if possible) , by gradual withdrawal of the drug presently being used 5. If 2nd line drug fails (due to above reasons)  start 2nd line drug, in combination with preferred 1st line drug at maximum tolerated doses (keep in mind possible interactions) 6. If above combination fails (due to above reasons)  replace 2nd line drug with alternative 2nd line drug
  • 28. 7. If above combination fails (due to above reasons)  check compliance & reconsider diagnosis, based on the following criteriae: a. If the events are seizures/ not b. Presence absence of occult lesions c. Treatment compliance/ alcohol/ drugs confounding responses 8. Consider alternative, non-drug treatments, like: a. Epilepsy surgery b. Vagal nerve stimulation 9. Use minimum number of drugs in combination at any one time………………………….
  • 29.  3. PHARMACOTHERAPY :  A. BARBITURATES : Include: I. PHENOBARBITONE (LUMINAL): - Drug has 3 actions: a. Drug  depresses sensory, motor cortex and cerebellum b. Drug  acts on GABA(A) receptors  increases synaptic inhibition  increases seizure threshold and decreases spread of seizure activity from a seizure focus c. Drug  inhibits CALCIUM channels  decreases excitatory transmitter release - ADR : a. Sedation c. Headache b. Respiratory depression (when given i.v)
  • 30. - DRUG INTERACTION: a. Phenobarbital + oral contraceptives  decreased efficacy of latter - USES: a. Febrile convulsions (8 mg/kg/day; child) b. GTC c. Neonatal seizures d. Status Epilepticus (SE) B. DEOXYBARBITURATES : Includes: I. PRIMIDONE (MYSOLINE): - MOA: Drug  enters body  metabolized by liver to PHENOBARBITONE  Shows remaining effects - ADR: a. STEVEN-JOHNSON SYNDROME (SJS) b. Hypotension c. Hepatitis
  • 31. - DRUG INTERACTION: a. BZDs + Drug  increased sedation - USES: A. GTCS (250-500 mg BD) B. Partial epilepsy C. HYDANTOINS : Includes: A. PHENYTOIN (BARBITOIN): - Drug has 3 actions: i. Drug  promotes sodium efflux/ decreased sodium influx from membranes in motor cortex neurons ii. Drug  stabilizes neuronal membranes iii. Drug  slows conduction velocity
  • 32. - ADR: i. Gingival hyperplasia ii. Hirsutism iii. Megaloblastic anemia iv. Diabetes mellitus v. FETAL HYDANTOIN SYNDROME (Drug  used in pregnancy  causes hare lips, microcephaly in neonates etc) - DRUG INTERACTIONS: a. Drug + Pyridoxine(in high dose)  decreased levels of phenytoin - USES: a. Tonic clonic seizures b. SE (10-15 mg/kg i.v/ infusion)
  • 33. B. FOSPHENYTOIN (FOSPHEN): - MOA: Drug  converted to PHENYTOIN after injection  shows actions of PHENYTOIN - ADR: a. Hypersensitivity b. SJS c. Hepatotoxicity - DRUG INTERACTIONS: a. Drug + CBZ(Carbamazepine)  decreased CBZ efficacy - USES: a. Seizures, associated with NEUROSURGERY/ HEAD INJURY b. SE (20 mg/kg i.v)………….
  • 34. D. IMINOSTILBENES : Includes: A. CARBAMAZEPINE (CARBATOL): - Drug shows 2 actions: i. Drug  stabilizes inactivated state of sodium channels  makes neurons less excitable ii. Drug  decreases activity of NUCLEUS VENTRALIS of thalamus / synaptic transmission associated with neuronal discharge - ADR: a. SJS b. Arrhythmia c. CHF - DRUG INTERACTIONS: a. Drug + warfarin  decreased anticoagulant effect - USES : a. Trigeminal neuralgia c. Epilepsy (200-400 mg TDS) b. Bipolar disorder
  • 35. B. OXCARBAZEPINE (CARBOX): - Drug shows 5 actions: i. Drug  blocks sodium channels  stabilizes neuronal membranes ii. Drug  inhibits repetitive firing iii. Drug  reduces synaptic impulse propagation iv. Drug  increases potassium conductance v. Drug  modulates activity of high voltage activated calcium channels - ADR: a. SJS b. Hepatitis c. Pancreatitis - DRUG INTERACTION: a. Furosemide + drug  increased risk of HYPONATREMIA - USES : a. Partial seizures , with/ without secondary generalization (in adults: 0.6-2.4 g/day, in divided doses)……………………
  • 36. E. SUCCINIMIDES: Includes: A. ETHOSUXIMIDE (ZARONTIN): - Drug shows 2 actions: i. Drug  depresses nerve transmission in motor cortex ii. Drug  increases convulsive stimuli threshold in CNS - ADR: a. GI disturbances b. Dizziness - DRUG INTERACTION: a. Drug + sodium oxybate  pharmacodynamic synergism  increased toxicity of each other  additive CNS depression - USE: a. Absence seizures : 500 mg P/O QID…………………….
  • 37. F. ALIPHATIC CARBOXYLIC ACIDS: Includes: I. VALPROIC ACID (VALPROL): - Drug shows 3 actions: i. Drug  increases GABA levels in brain ii. Drug  increases / mimics action of GABA at postsynaptic receptor sites iii. Drug  inhibits sodium and calcium channels - ADR: a. SJS b. Pancreatitis c. Thrombocytopenia - DRUG INTERACTION: a. Drug + Chlorpromazine  severe HEPATOTOXICITY - USES: a. Complex partial seizures (For adults: max. 60 mg/kg/day) b. Simple and complex absence seizures…………………..
  • 38. II. DIVALPROEX (DIVAA): - MOA : Same as that of SODIUM VALPROATE - ADR: a. Increased bleeding time b. Encephalopathy c. Dementia - DRUG INTERACTION : a. Drug + cholestyramine  decreased levels of divalproex - USES : a. Complex partial seizures (max.: 60 mg/kg/day) b. Mania c. Migraine prophylaxis d. Simple and complex absence seizures………………………………
  • 39. G. BENZODIAZEPINES : Includes: I. CLONAZEPAM (CLONA): - Long acting BZD - Drug shows 3 actions: a. Drug  increases presynaptic GABA inhibition b. Drug  decreases monosynaptic and polysynaptic reflexes c. Drug  facilitates GABA neurotransmission and other inhibitory neurotransmitters  suppresses muscle contractions - ADR: a. Blood disorders b. Increased LFTs c. Respiratory depression - DRUG INTERACTION: a. Amiodarone + drug  increased drug toxicity
  • 40. - USES: a. Panic disorder b. Seizure disorders (For adult: up to 1.5 g , in 3 divided doses) c. SE II. CLOBAZAM (CLOBA): - 1,5- BENZODIAZEPINE (Contrary to others) - MOA: Drug  binds to GABA(A) receptor  potentiates GABA- ergic neurotransmission - ADR: a. Hypotension b. Respiratory depression c. Jaundice - DRUG INTERACTION: a. CBZ + Clobazam  decreased drug levels b. Alcohol + Clobazam  increased drug levels
  • 41. III. DIAZEPAM (DIZEP): - Drug shows 2 actions: a. Drug  modulates postsynaptic effects of GABA(A) transmission  results in an increase in presynaptic inhibition b. Drug  acts on part of limbic system, thalamus and hypothalamus  induces CALMING EFFECT - ADR: a. Respiratory depression b. Hypotension c. Jaundice - DRUG INTERACTION: a. Hormonal contraceptives + Drug  increased drug effects  increased incidence of BREATH-THROUGH BLEEDING
  • 42. - USES: a. STATUS EPILEPTICUS (Adult: 5-10 mg every 5-10 mins. ; maximum 30 mg.) b. Anxiety c. Conscious sedation for procedures d. Ethanol withdrawal e. Insomnia associated with anxiety f. Muscle spasm with tetanus g. Night terrors h. Sedation i. Skeletal muscle relaxation j. Sleep walking………………………………..
  • 43. IV. LORAZEPAM (LOPEZ): - Short onset of effect - Long half-life - Drug shows 2 actions: a. Drug  increases action of GABA b. Drug  depresses all levels of CNS, including lumbar and reticular formation - ADR: a. Respiratory depression b. Hypotension c. Jaundice - DRUG INTERACTIONS: a. Loxapine + drug  increased respiratory depression b. Zidovudine + drug  increased headache
  • 44. - USES: a. Antiemetic (adjuvant therapy) b. Acute anxiety c. Insomnia associated with anxiety d. Panic disorder e. Pre-operative medication f. Sedation g. SE (For adult: 4 mg; repeat once after 10 mins, if necessary)………………………..
  • 45. H. PHENYLTRIAZINES: Includes: LAMOTRIGINE (LAMORIN): - Drug shows 2 actions: a. Drug  inhibits release of excitatory amino acids (glutamate) b. Drug  inhibits voltage sensitive sodium channels  stabilizes neuronal membranes - ADR: a. SJS b. DIC c. Lymphadenopathy - DRUG INTERACTION: a. Drug + Phenytoin/Phenobarbital  decreases levels of drug - USES: a. Bipolar disorder b. GTC( For adult: 25 mg/day for initial 14 days  then increase dose to 50 mg/day for next 14 days  then increase dose to 50-100 mg/day for next 7-14 days)……………………..
  • 46. I. CYCLIC GABA ANALOGUES: Includes: A. GABAPENTIN (GABAPENTIN): - Structurally related to GABA, but has no effect on GABA binding, uptake/ degradation - MOA: Drug  modulates voltage sensitive calcium channels  decreases entry of calcium into presynaptic neurons  decreases glutamate release  decreases neuronal excitability - ADR : a. SJS b. ARF c. Hepatitis - DRUG INTERACTION: a. Drug + phenytoin/antacids decreased levels of latter
  • 47. - USES: a. Diabetic neuropathy b. Focal seizures, with/ without secondary generalization (For child: 12-18 yrs  300 mg TID/ 0.9-3.6g/day ,in 3 divided doses) c. Restless legs syndrome d. Post- therpetic neuralgia / neuropathic pain……………… B. PREGABALIN (PREGALIN): - Drug shows 2 actions: i. Drug  binds to a subunit of voltage gated calcium channels in CNS  remaining same as GABAPENTIN ii. Does not affect sodium channels - ADR: a. Primary AV block b. CHF c. SJS
  • 48. - DRUG INTERACTIONS: a. Drug + Lorazepam/ alcohol  increased efficacy of latter - USES: a. Partial seizures, with/ without secondary generalization (50-300 mg/day, in 2-3 divided doses, for adults; maximum: 600 mg/day) b. Anxiety c. Peripheral and central neuropathic pain d. Fibromyalgia……………………………..
  • 49. J. NEWER DRUGS: Include: I .TOPIRAMATE II.ZONISAMIDE III. LEVETIRACETAM IV. VIGABATRIN V. TIAGABINE VI. LACOSAMIDE VII. FELBAMATE VIII. RUFINAMIDE IX. STIRIPENTOL X. ESLICARBAZEPINE ACETATE XI. PERAMPANEL…………………………………..
  • 50. I. TOPIRAMATE (TOPIRATE): - CLASS: SULFAMATE SUBSTITUTED DERIVATIVE - Drug shows 2 actions: a. Drug  inhibits neuronal voltage dependent sodium channels b. Drug  enhances activity of GABA - ADR: a. SJS b. Thrombocytopenia c. Toxic epidermal necrolysis(TEN) - DRUG INTERACTION: a. Zonisamide+ drug  increased risk of renal calculi - USES: a. Epilepsy (200-1000 mg/day) b. Migraine prophylaxis c. Partial seizures……………………………….
  • 51. II. ZONISAMIDE (ZONICARE): - CLASS: SULFONAMIDE DERIVATIVE (Benzisoxazole compound) - Drug shows 3 actions: a. Drug  acts at sodium and calcium channels  stabilizes neuronal membranes b. Does not affect GABA activity c. More active against TONIC PHASE than against CLONIC PHASE - ADR: a. SJS b. TEN c. Rhabdomyolysis - DRUG INTERACTION: a. CBZ+ Zonisamide  decreased level of Zonisamide (by affecting CYP3A4 metabolism) - USES: a. Partial seizures, with/ without secondary generalization (300-500 mg/ day; in 1-2 divided doses)……………………………………..
  • 52. III. LEVETIRACETAM (LEVACETAM): - CLASS: PYRROLIDINE DERIVATIVE - Drug shows 3 actions: a. Drug  inhibits voltage dependent N-TYPE CALCIUM CHANNELS b. Drug  binds to synaptic proteins  modulate neurotransmitter release c. Drug  displaces negative modulators  facilitates GABA- ergic inhibitory transmission - DRUG INTERACTION: a. CBZ + Drug  CBZ toxicity occurs - ADR: a. Thrombocytopenia b. Pancreatitis c. Hepatic dysfunction - USES: a. GTC (Max: 1.5 g BID; For adults) b. Myoclonic seizures c. Partial seizures, with or without secondary generalization………………….
  • 53. IV. VIGABATRIN (SABRIL): - CLASS: GAMMA-VINYL GABA DERIVATIVE - MOA: Drug  irreversibly inhibits GABA-transaminase  increases GABA levels in brain - ADR: a. Weight gain in children (47%) b. Permanent bilateral concentric visual field constriction (>30%) c. Fatigue (28%) - DRUG INTERACTION: a. Drug + CLOBAZAM  Increased sedation, respiratory depression - USES: a. Complex seizures (1.5 g BID) b. Partial seizures c. Infantile spasms d. Refractory complex seizures………………………….
  • 54. V. TIAGABINE (GABITRIL): - CLASS: GABA REUPTAKE INHIBITOR - MOA: drug  blocks GABA reuptake by presynaptic neuron  increases its activity in nervous system - ADR: a. Dizziness (26-30%) b. Asthenia (16-20%) c. Somnolence (16-20%) - DRUG INTERACTION: a. Drug + Clobazam  increased sedation/ respiratory depression - USES: a. Partial seizures (with hepatic enzyme inducing anticonvulsants) b. Partial seizures (without hepatic enzyme inducing anticonvulsants; 12-22 mg/day , divided in 2-3 doses)…………………………………
  • 55. VI. LACOSAMIDE (LACOSAM): - CLASS : HOMOSERINAMIDE DERIVATIVE; FUNTIONAL AMINO ACID - Drug shows 2 actions: a. Drug  slowly inactivates voltage gated sodium channels b. Drug  binds to collapsin response mediator protein-2 (CRMP-2); a phosphoprotein; expressed mainly in nervous system  modulates neuronal differentiation and axonal outgrowth - ADR: a. Dizziness (31%) d. Atrial fibrillation b. Diplopia (11%) e. Atrial flutter c. Headache (11%) f. Suicidal ideation - DRUG INTERACTION: a. Drug + anti- arrhythmics  enhanced PR-prolongation - USES: a. Neuropathic pain b. Partial seizures (200-400 mg/day)…….
  • 56. VII. FELBAMATE (FELBATOL): - CLASS : CARBAMATE DERIVATIVE - Drug shows 2 actions: a. Drug  positive modulator of GABA(A) receptor b. Drug  blocks NMDA receptors (NR2B subunit) - ADR: a. Anorexia b. Liver failure c. Aplastic anemia - DRUG INTERACTION: a. Felbamate + clopidogrel  decreased effects of clopidogrel - USES: a. Partial seizures, with/ without secondary generalization (Adults: 1,200 mg Q6H/Q8H) b. Partial/ Generalized seizures , associated with LENNOX-GASTAUT SYNDROME …….
  • 57. VIII. RUFINAMIDE (BANZEL): - CLASS : TRIAZOLE DERIVATIVE - MOA: Drug  modulates activity of sodium channels  prolongs their inactive state  limits repetitive firing of sodium dependent action potentials  anticonvulsant effect - ADR: a. Diplopia b. SJS c. Dizziness - DRUG INTERACTION : a. Rufinamide + alprazolam  decreased levels/ effects of latter - USE: a. LENNOX-GASTAUT SYNDROME (3,200 mg/day maximum, in 2 divided doses)……………………………..
  • 58. IX. STIRIPENTOL (DIACOMIT): - CLASS: AROMATIC ALLYLIC ALCOHOLS - Drug shows 5 actions: a. Drug  increases GABA transmission b. Drug  increases duration of opening of GABA(A) receptor channels in hippocampal areas  enhances central GABA transmission c. Drug  increases GABA levels in brain tissues by interfering with its uptake & metabolism d. Drug  inhibits LACTATE DEHYDROGENASE  Makes neurons less prone to fire action potentials e. Drug  improves effectiveness of other anti-convulsants…………… - ADR: a. Hyperkinesia b. Drowsiness c. Ataxia
  • 59. - DRUG INTERACTION: a. Drug + CBZ/ Phenobarbital  increased efficacy/ potency of latter - USES: a. DRAVET SYNDROME (Along with sodium valproate and Clobazam; 50 mg/kg/day) b. Epilepsy in infancy c. Refractory childhood epilepsy( in combination with CBZ)…………. X. ESLICARBAZEPINE ACETATE (ESLIZEN): - CLASS : DIBENZAPINE CARBOXAMIDE DERIVATIVE - Drug shows 3 actions: a. PRODRUG  activated to ESLICARBAZEPINE/ S-LICARBAZEPINE (Major active metabolite of OXCARBAZEPINE)  Blocks sodium channels  inhibits repetitive firing  decreases synaptic impulse propagation  stabilizes neuronal membranes b. Drug  increases potassium conductance c. Drug  modulates activity of high voltage gated activated calcium channels
  • 60. - ADR: a. Blurred vision b. HTN c. Peripheral edema - DRUG INTERACTION: a. Drug + Phenytoin/ Barbiturates  decreased drug levels - USE: a. Partial onset seizures (for adult: 400 mg/day; for 7 days)……………….
  • 61. XI. PERAMPANEL (FYCOMPA): - CLASS : NON-COMPETITIVE AMPA RECEPTOR ANTAGONIST) - MOA: Drug  non- competitively blocks ALPHA-AMINO-3-HYDROXY-5-METHYL-4- ISOXAZOLEPROPIONIC ACID (AMPA ) glutamate receptor on post synaptic neurons  decreased glutamate activity  decreases neurological disorders causes by glutamate over- excitation - ADR: a. Dizziness (16-43%) b. Somnolence (9-18%) c. Suicidal ideation (notorious) - DRUG INTERACTION: a. Drug +CBZ  Decreased perampanel effectiveness - USES: a. Partial onset seizures (8-12 mg/day) b. Tonic clonic seizures……………….
  • 62.  4. GUIDELINES FOR CHOICE OF ANTI-EPILEPTIC DRUGS  : A. FOR FOCAL ONSET AND / SECONDARY GTCS: - IST LINE DRUG : LAMOTRIGINE - 2ND LINE DRUGS : CBZ, LEVETIRACETAM, VALPROIC ACID, TOPIRAMATE , ZONISAMIDE, LACOSAMIDE - 3RD LINE DRUGS: CLOBAZAM, GABAPENTIN, OXCARBAZEPINE, BARBITURATES , PHENYTOIN, PREGABALIN, PRIMIDONE, TIAGABINE….. B. FOR GTCS: - 1ST LINE DRUGS : VALPROIC ACID, LEVETIRACETAM - 2ND LINE DRUGS : LAMOTRIGINE, TOPIRAMATE, ZONISAMIDE - 3RD LINE DRUGS : CBZ, PHENYTOIN, PRIMIDONE, BARBITURATES……………
  • 63. C. FOR ABSENCE SEIZURES : - 1ST LINE DRUG : ETHOSUXIMIDE - 2ND LINE DRUGS : SODIUM VALPROATE - 3RD LINE DRUGS : LAMOTRIGINE, CLONAZEPAM…………… D. FOR MYOCLONIC SEIZURES: - 1ST LINE DRUG: SODIUM VALPROATE - 2ND LINE DRUGS : LEVETIRACETAM, CLONAZEPAM - 3RD LINE DRUGS : LAMOTRIGINE, PHENOBARBITAL………………………
  • 64.  5. NON- PHARMACOTHERAPY/PATIENT- COUNSELLING TIPS +HOME REMEDIES FOR EPILEPSY  :1. AVOID ACTIVITIES, WHERE PATIENTS MAY PLACE THEMSELVES/ OTHERS AT RISK, IF THEY HAVE A SEIZURE (APPLIES AT WORK, HOME/ AT LEISURE) 2. TAKE ONLY SHALLOW BATHS/ SHOWERS 3. AVOID PROLONGED CYCLE JOURNEYS ,UNLESS REASONABLE FREEDOM FROM SEIZURES HAS BEEN ACHIEVED 4. ACTIVITIES, THAT REQUIRE PROLONGED PROXIMITY TO WATER (FISHING SWIMMINING,BOATING ) SHOULD BE
  • 65. 5. RECONGIZED MORTALITY OF EPILEPSY SHOULD BE DISCUSSED AT THE TIME OF DIAGNOSIS, AIMED AT MOTIVATING THE PATIENT, TO ADAPT TO HABITS AND LIFESTYLE, TO OPTIMIZE EPILEPSY CONTROL 6. COCONUT OIL: - Highly effective - Fatty acids (medium chain triglycerides) in oil  possess therapeutic effects on brain cells - Oil  supplies energy for brain cells  relieves epilepsy symptoms - Use 1-3 tsp of EXTRA VIRGIN COCONUT OIL (3 times a day) 7. EPSOM SALT: - EPSOM SALT  Contains magnesium sulphate  changes psychochemical cell relationships in the brain  reduces frequency of seizures and convulsions - Use in the form of: a. Epsom salt bath (2-3 times/ week) b. Add half tsp of salt to orange juice / water  drink every morning
  • 66. 8. LIME: - Popular Ayurvedic remedy - Lime  helps improve blood circulation to brain - Also normalizes excess calcium that may hamper brain functionality - Use in the form of: a. (2 tsp. lime juice + half tsp. baking soda + water)  drink daily before going to bed b. Apply lime juice on head  massage thoroughly for a few mins.  do daily before taking a shower 9. GARLIC: - Garlic  possesses ANTIOXIDANT, ANTISPASMODIC & ANTI-INFLAMMATORY PROPERTIES  Promotes proper functioning of nervous, along with destruction of harmful free radicals in body  prevents seizures and related symptoms - Use it in the form of: a. Mix half cup of milk + half cup water  boil  add 4-5 crushed garlic cloves  strain and drink it once daily b. Garlic supplements (under doctor advice)
  • 67. 10. PASSIONFLOWER : - Herb  contains CHRYSIN  increases GABA amount in brain  decreases seizures frequency, anxiety - Use it in the form of : a. CAPSULE, TABLET FORMS b. HERBAL TEA (1-2 CUPS) - Avoid in pregnancy/ lactation 11. WINTER MELON: - Also known as ‘ASH GOURD’ - Popular Ayurvedic remedy - Vegetable  helps keeps nervous system healthy - Also ensures smooth functioning of brain cells - Use in the form of: a. Half glass winter melon juice + little sugar  drink in the morning on empty stomach b. Extract juice of crushed winter melon  add 1-2 tsp licorice powder to it  mix well  drink this solution once daily
  • 68. 12. EXERCISE : - Improves fitness, energy and mood  reduces seizures and impact of epilepsy on one’s life - Exercise  releases positive feeling hormones into brain  increases oxygen flow to brain - Go for warm up/ stretching exercises - Walk for 45 mins. , 4 times a week - Drink water before and after exercise to prevent dehydration - Stop and rest if you are feeling tired 13. YOGA: - Alleviates stress - Induces relaxation - Combination of DEEP BREATHING, PHYSICAL POSTURES AND MEDITATION  Controls seizures and reduces other epilepsy symptoms - Best yoga poses for epilepsy are: a. Balasana(child’s pose) b. Nadi shodhana(alternate nostril breathing) c. Kapotasana (pigeon pose) d. Sirsasana (headstand)
  • 69. 14. VITAMINS: - Certain vitamins  control neurons that cause seizures and anxiety disorders - Consume the following Vitamin supplements after doctor consultation: a. Vitamin E b. Vitamin B6 c. Vitamin B1 d. Vitamin D e. Vitamin B12 15. ACCUPUNCTURE: - “Phenomenon of applying pressure to specific points on the body, by using fine needles” - Acupuncture  restores flow of energy throughout the body  alters brain activity  reduces seizures 16. COUNSELLING TIPS IN PREGNANCY: - Start FOLIC ACID 5 mg daily for 2 months before conception , to reduce risk of AED induced fetal abnormalities - Since some AEDs are associated with hemorrhage risk, give oral Vitamin K 20 mg daily to mother during last month of pregnancy, and Vitamin K (1 mg i.m ) to infant at birth 17. GET ENOUGH SLEEP, AS SLEEP DEPRIVATION TRIGGERS SEIZURES 18. MANAGE STRESS AND AVOID STRESSFUL SITUATIONS
  • 70. 19. IF YOU HAVE SEIZURES REGULARLY, WEAR A ‘MEDICAL ALERT BRACELET’  THIS WILLHELP PEOPLE TO KNOW ABOUT YOUR CONDITION 20. DRINK HALF GLASS OF GRAPE JUICE DAILY 21. LIMIT ALCOHOL INTAKE 22. AVOID SMOKING 23. LOW CALCIUM AND MAGNESIUM  TRIGGERS SEIZURES  CONSUME FOODS RICH IN THEM 24. AVOID ALL ‘WHITE PRODUCTS’ LIKE: a. White sugar b. White flour c. Table salt d. White rice
  • 71. 25. DO NOT SKIP MEALS, ESPECIALLY BREAKFAST 26. DO NOT CONSUME ARTIFICIAL SWEETENERS/ ADDITIVES 27. TAKE MEDICINES PRESCRIBED BY DOCTOR IN CORRECT DOSAGES IN A TIMELY MANNER 28. DO NOT SKIP TAKING YOUR MEDICINES WITHOUT DOCTOR’S APPROVAL 29. AVOID USAGE OF GINGKO BILOBA AND ST.JOHN’S WORT FOR EPILEPSY ,UNLESS UNDER DOCTOR’S ADVICE (SINCE THEY CAN INTERACT WITH AEDs) 30. FOLLOW A KETOGENIC DIET, COMPRISING: a. High fat(nuts, cream, butter) b. Low carbohydrate (starchy fruits, bread, pasta, grains, sugar)
  • 72.  BIBLIOGRAPHY/ REFERENCE  : 1. DAVENPORT.J.R; LEACH.P.J; ‘NEUROLOGICAL DISEASE:EPILEPSY’;DAVIDSON’S PRINCIPLES AND PRACTICE OF MEDICINE; 22ND EDITION; Pg:1178-85 2. Tripathi.K.D; “Essentials of medical pharmacology”; 7th edition; Jaypee Publishers; “Anti- epileptic drugs’; Pg:411-424 3. Dhillon.S; Sander.W.J; “Clinical pharmacy and therapeutics”; by Roger Walker; 5th edition; “Epilepsy”; Pg: 489 4. Wells.G.Barbera;”Epilepsy”; Pharmacotherapy Handbook; by Joseph.T.Dipiro; Pg: 577 5. www.healthline.com 6. www.drugbank.com 7. www.webmd.com 8. http://www.thelancet.com/journals/abstract/’Top 10 home remedies To deal with Epilepsy’ 9. Razzhaghi.A; “Seizure disorders”; “Comprehensive Pharmacy Review for NAPLEX by LEON SHARGEL”; 8TH EDITION; Pg:743 10. Mc.Namara.C.J; “Pharmacotherapy of the Epilepsies”; Goodman & Gilman’s Pharmacological basis of Therapeutics; 11th edition; Pg: 501
  • 73. THANK YOU!!!    @rxvichu-alwz4uh!!